<SEC-DOCUMENT>0001104659-25-046813.txt : 20250509
<SEC-HEADER>0001104659-25-046813.hdr.sgml : 20250509
<ACCEPTANCE-DATETIME>20250509165654
ACCESSION NUMBER:		0001104659-25-046813
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250507
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250509
DATE AS OF CHANGE:		20250509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TACTILE SYSTEMS TECHNOLOGY INC
		CENTRAL INDEX KEY:			0001027838
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37799
		FILM NUMBER:		25931372

	BUSINESS ADDRESS:	
		STREET 1:		1331 TYLER STREET NE STE 200
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55413
		BUSINESS PHONE:		866-435-3948

	MAIL ADDRESS:	
		STREET 1:		1331 TYLER STREET NE STE 200
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55413
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2514641d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:TCMD="http://tactilemedical.com/20250507">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_TCMD_tactilemedical.com_20250507 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20250507_20250507 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0001027838 -->
<!-- Field: Set; Name: xdx; ID: xdx_072_SO_T%2D%2D\DeptFiles%2DiXBRL 8%2DK Covers Templates\+++%2DROOT%2DElement%2D+++\DocumentInformationLineItems.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000004" name="dei:EntityCentralIndexKey">0001027838</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-05-07" id="xdx2ixbrl0012" name="dei:EntityRegistrantName">TACTILE SYSTEMS TECHNOLOGY INC</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="tcmd-20250507.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-05-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001027838</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-07</xbrli:startDate>
        <xbrli:endDate>2025-05-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES<br/>
SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->


<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_905_edei--DocumentType_c20250507__20250507_ztV3nTdhPtZj"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000010" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>


<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>&#160;</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<b>&#160;<span id="xdx_90C_edei--DocumentPeriodEndDate_c20250507__20250507_zua6w36heiWf"><ix:nonNumeric contextRef="AsOf2025-05-07" format="ixt:datemonthdayyearen" id="Fact000011" name="dei:DocumentPeriodEndDate">May 7, 2025</ix:nonNumeric></span></b></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 2in 2pt; text-align: center"><b>&#160;</b></p>


<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90C_edei--EntityRegistrantName_dxL_c20250507__20250507_zcecUhyGLnHh" title="::XDX::TACTILE%20SYSTEMS%20TECHNOLOGY%20INC"><b><span style="-sec-ix-hidden: xdx2ixbrl0012">TACTILE
SYSTEMS TECHNOLOGY, INC.</span></b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 2in 2pt; text-align: center">(Exact name
of registrant as specified in its charter)</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>




<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; text-align: center; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityIncorporationStateCountryCode_c20250507__20250507_zh13T4XFlyBa"><ix:nonNumeric contextRef="AsOf2025-05-07" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 32%"><span id="xdx_90C_edei--EntityFileNumber_c20250507__20250507_zA8QL5e5v2Ha" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000014" name="dei:EntityFileNumber">001-37799</ix:nonNumeric></b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 33%"><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20250507__20250507_zSD2CKWVeZXd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000015" name="dei:EntityTaxIdentificationNumber">41-1801204</ix:nonNumeric></b></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_904_edei--EntityAddressAddressLine1_c20250507__20250507_zJDp1QA8ycOf"><b><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000016" name="dei:EntityAddressAddressLine1">3701
Wayzata Blvd</ix:nonNumeric></b></span><b>, <span id="xdx_907_edei--EntityAddressAddressLine2_c20250507__20250507_zogDPn9Ktfbd"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000017" name="dei:EntityAddressAddressLine2">Suite 300</ix:nonNumeric></span></b><b>,
<span id="xdx_909_edei--EntityAddressCityOrTown_c20250507__20250507_zWLyBy14CmI7"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000018" name="dei:EntityAddressCityOrTown">Minneapolis</ix:nonNumeric></span></b><b>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20250507__20250507_z0CXWJigPEvc"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000019" name="dei:EntityAddressStateOrProvince">MN</ix:nonNumeric>
</span></b><b><span id="xdx_903_edei--EntityAddressPostalZipCode_c20250507__20250507_zjWLa4gdQJaf"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000020" name="dei:EntityAddressPostalZipCode">55416</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices) (Zip
Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_90E_edei--CityAreaCode_c20250507__20250507_zib2G9k4EeE9"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000021" name="dei:CityAreaCode">612</ix:nonNumeric></span></b><b>)
<span id="xdx_90A_edei--LocalPhoneNumber_c20250507__20250507_zq1icCAsBCDb"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000022" name="dei:LocalPhoneNumber">355-5100</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_902_edei--WrittenCommunications_c20250507__20250507_zOGLxnglRmK2" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2025-05-07" format="ixt:booleanfalse" id="Fact000023" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span>&#160;Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_904_edei--SolicitingMaterial_c20250507__20250507_zOafupNayOpl" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2025-05-07" format="ixt:booleanfalse" id="Fact000024" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span>&#160;Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-indent: -0.2in"><span id="xdx_900_edei--PreCommencementTenderOffer_c20250507__20250507_za1UWyBnhAE5" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2025-05-07" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span>&#160;Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-indent: -0.2in"><span id="xdx_90D_edei--PreCommencementIssuerTenderOffer_c20250507__20250507_z65g4hWUnE7j" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2025-05-07" format="ixt:booleanfalse" id="Fact000026" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span>&#160;Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-indent: -0.2in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Securities registered
pursuant to Section 12(b) of the Act:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which <br/>
    registered</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_902_edei--Security12bTitle_c20250507__20250507_zz176e9wywE7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000027" name="dei:Security12bTitle">Common
    Stock, Par Value $0.001 Per Share</ix:nonNumeric></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90A_edei--TradingSymbol_c20250507__20250507_z3EZuYZxPGcg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000028" name="dei:TradingSymbol">TCMD</ix:nonNumeric></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90C_edei--SecurityExchangeName_c20250507__20250507_zOayUMrGYD49" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-05-07" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-indent: -0.2in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of
the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#160;&#160;<span style="font-family: Wingdings"><span id="xdx_907_edei--EntityEmergingGrowthCompany_c20250507__20250507_zZY5UoO1YGa"><ix:nonNumeric contextRef="AsOf2025-05-07" format="ixt:booleanfalse" id="Fact000030" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span>
Emerging growth company</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><span style="font-size: 10pt"><b>Item 5.02.</b></span></td><td style="text-align: justify"><b><span style="text-decoration: underline">Departure of Directors of Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers</span></b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As reported below in Item
5.07, on May&#160;7, 2025, the stockholders of Tactile Systems Technology,&#160;Inc. (the &#8220;Company&#8221;) approved the Tactile
Systems Technology,&#160;Inc. 2025 Equity Incentive Plan (the &#8220;2025 Plan&#8221;). The 2025 Plan was approved by the Company's Board
of Directors (the "Board") on March&#160;25, 2025, subject to stockholder approval, and became effective with such stockholder
approval on May&#160;7, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The 2025 Plan provides for
the issuance of up to 1,850,000 shares of the Company's common stock,&#160;par value $0.001 per share (the &#8220;Common Stock&#8221;).
Any shares of Common Stock subject to an award under the 2025 Plan, or to an award under the Company&#8217;s 2016 Equity Incentive Plan
(the &#8220;2016 Plan&#8221;) that was outstanding on May&#160;7, 2025, that expires, is forfeited or cancelled, is settled for cash or
otherwise does not result in the issuance of all of the shares subject to such award will, to the extent of such cancellation, forfeiture,
expiration, cash settlement or non-issuance, become available for future awards under the 2025 Plan. Following the stockholders' approval
of the 2025 Plan, no further awards will be granted under the 2016 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Awards under the 2025 Plan
may be granted to employees, consultants and advisors of the Company, as well as to the non-employee directors of the Company. Awards
under the 2025 Plan can be granted in the form of stock options, stock appreciation rights, restricted stock, restricted stock units and
other stock-based awards. The 2025 Plan will be administered by the Compensation and Organization Committee of the Company's Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A description of the 2025
Plan was included in the Company&#8217;s proxy statement for its annual meeting of stockholders filed with the Securities and Exchange
Commission on March&#160;28, 2025. A copy of the 2025 Plan, the Form&#160;of Restricted Stock Unit Award Agreement (Executives) for use
under the 2025 Plan, the Form&#160;of Restricted Stock Unit Award Agreement (Non-Employee Directors) for use under the 2025 Plan and the
Form&#160;of Performance Stock Unit Agreement for use under the 2025 Plan are filed as Exhibit&#160;10.1, 10.2, 10.3 and 10.4, respectively,
to this Current Report on Form&#160;8-K and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>Item 5.07.</b></td><td style="text-align: justify"><b><span style="text-decoration: underline">Submission of Matters to a Vote of Security Holders</span></b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;7, 2025, the Company
held its 2025 Annual Meeting of Stockholders and the Company&#8217;s stockholders voted on the following matters:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Election of Directors</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following nominees were
elected to serve as directors for a term that will last until the Company&#8217;s 2026 Annual Meeting of Stockholders or until his or
her successor is duly elected and qualified. The number of votes cast for and withheld from each nominee and the number of broker non-votes
with respect to each nominee were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify">Name</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Votes For</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Votes Withheld</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Broker Non-Votes</td><td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: left">William W. Burke</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">15,557,077</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">436,231</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">3,037,240</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Valerie L. Asbury</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">15,267,124</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">726,184</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">3,037,240</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sheri L. Dodd</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">15,796,147</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">197,161</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">3,037,240</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Raymond O. Huggenberger</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">15,756,282</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">237,026</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">3,037,240</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Laura G. King</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">15,862,873</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">130,435</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">3,037,240</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">D. Brent Shafer</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">14,929,921</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1,063,387</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">3,037,240</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Carmen B. Volkart</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">15,796,104</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">197,204</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">3,037,240</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">B. Vindell Washington</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">15,774,288</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">219,020</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">3,037,240</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Ratification of the Selection of Grant Thornton
LLP as the Company&#8217;s Independent Auditor for 2025</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s stockholders
ratified the appointment by the Audit Committee of the Company&#8217;s Board of Directors of Grant Thornton LLP as the Company&#8217;s
independent registered public accounting firm for the year ending December&#160;31, 2025 by voting as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">For</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; white-space: nowrap; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Against</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; white-space: nowrap; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; white-space: nowrap; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Abstain</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; white-space: nowrap; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; white-space: nowrap; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Broker Non-Votes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; white-space: nowrap; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: center">18,900,463</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center">121,340</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center">8,745</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center">0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Advisory Vote on Approval of the Compensation
of the Company&#8217;s Named Executive Officers</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s stockholders
approved, on an advisory basis, the compensation of the Company&#8217;s named executive officers by voting as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">For</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Against</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Abstain</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Broker Non-Votes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: center">15,658,844</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center">321,637</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center">12,827</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center">3,037,240</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Advisory Vote on the Frequency of Future Advisory
Votes on the Compensation of the Company&#8217;s Named Executive Officers</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s stockholders
voted as follows on the frequency of future advisory votes on the compensation of the Company&#8217;s named executive officers:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">1 Year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; white-space: nowrap; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">2 Years</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; white-space: nowrap; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; white-space: nowrap; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">3 Years</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; white-space: nowrap; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; white-space: nowrap; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Abstain</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; white-space: nowrap; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; white-space: nowrap; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Broker Non-Votes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; white-space: nowrap; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: center">14,948,653</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center">7,171</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center">1,020,661</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center">16,823</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: center">3,037,240</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based
on these results, and consistent with the Board&#8217;s recommendation, the Board has determined that the Company will hold future advisory
votes to approve the compensation of the Company&#8217;s named executive officers every year, until the next required vote on the frequency
of future advisory votes on executive compensation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Approval of the Company&#8217;s 2025 Equity
Incentive Plan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s stockholders
approved the Company&#8217;s 2025 Equity Incentive Plan by voting as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">For</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Against</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Abstain</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Broker Non-Votes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: center">15,286,584</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center">697,589</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center">9,135</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center">3,037,240</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>Item 9.01.</b></td><td style="text-align: justify"><b><span style="text-decoration: underline">Financial Statements and Exhibits</span></b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EXHIBIT&#160;INDEX</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br/>
No.</b></span></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 88%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><a href="tm2514641d1_10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2514641d1_10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tactile Systems Technology,&#160;Inc. 2025 Equity Incentive Plan.</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><a href="tm2514641d1_10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2514641d1_10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Restricted Stock Unit Award Agreement (Executives) under the 2025 Equity Incentive Plan.</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><a href="tm2514641d1_10-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2514641d1_10-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Restricted Stock Unit Award Agreement (Non-Employee Directors) under the 2025 Equity Incentive Plan.</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><a href="tm2514641d1_10-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2514641d1_10-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Performance Stock Unit Agreement under the 2025 Equity Incentive Plan.</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">TACTILE SYSTEMS TECHNOLOGY,&#160;INC.</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt; width: 50%"><span style="font-size: 10pt"><span style="font-size: 10pt">Date: May&#160;9, 2025</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"> <i>/s/ Elaine M. Birkemeyer</i></td></tr>
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Elaine M. Birkemeyer&#160;</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: italic 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Chief Financial Officer</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2WUq3esjHxCKyCInodckxlnRHZrfST+ov25RoGBiGe8+9QoRiQ2tdI8NlVeRwwqatlUMosEJGc0XvSLe7BPwt8KatY2Xc8P7AlDyDnllMpFReGKxPbbFMIJpP4+VUziFaJnIGx70IvnpKptIlGqdVDcqUcGRqWaNT3I8JJ9WRoaYfqs7IVpNJIJ5Eo/wGGcUSDvRUL+K7hTxPRRAOE4gN06P1rqxzaL4kZDU2vs6O9H+DDwsKSpQ= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2514641d1_10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2025 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Purpose</U>.</FONT></B><FONT STYLE="font-size: 10pt">
The purpose of the Tactile Systems Technology,&nbsp;Inc. 2025 Equity Incentive Plan (the &ldquo;Plan&rdquo;), is to attract, retain and
motivate the best available service providers for positions of responsibility with the Company, to provide additional equity incentives
to them that are intended to align their interests with those of the Company&rsquo;s stockholders, and to thereby promote the Company&rsquo;s
long-term business success.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Definitions</U>.</FONT></B><FONT STYLE="font-size: 10pt">
In this Plan, the following definitions will apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Affiliate&rdquo;
means any entity that is a Subsidiary or Parent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Agreement&rdquo;
means the written or electronic agreement, notice or other document containing the terms and conditions applicable to each Award granted
under the Plan. An Agreement is subject to the terms and conditions of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Award&rdquo;
means a grant made under the Plan in the form of Options, Stock Appreciation Rights, Restricted Stock, Stock Units, or an Other Stock-Based
Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Board&rdquo;
means the Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Cause&rdquo;
means what the term is expressly defined to mean in a then-effective written agreement (including an Agreement) between a Participant
and the Company or any Affiliate, or in the absence of any such then-effective agreement or definition, means: (i)&nbsp;an act or acts
of dishonesty undertaken by the Participant and intended to result in personal gain or enrichment of the Participant or others at the
expense of the Company; (ii)&nbsp;unlawful conduct or gross misconduct by the Participant that, in either event, is materially injurious
to the Company; (iii)&nbsp;the Participant being convicted of a felony; or (iv)&nbsp;any material breach by the Participant of any terms
or conditions of any written agreement between the Participant and the Company which breach has not been cured by the Participant within
15 days after written notice thereof to the Participant from the Company. For the purposes of clauses (ii)&nbsp;and (iv)&nbsp;above, no
act or failure to act on the part of the Participant shall be considered &ldquo;Cause&rdquo; if done by the Participant pursuant to specific
authorization evidenced by a resolution duly adopted by the Board or pursuant to specific advice given by counsel for the Company, unless
such specific authorization or advice results in whole or in part from material misrepresentations or omissions by the Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Change
in Control&rdquo; means, unless otherwise provided in an Agreement, one of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">An
Exchange Act Person becomes the beneficial owner (within the meaning of Rule&nbsp;13d-3 under the Exchange Act) of securities of the Company
representing more than 50% of the combined voting power of the Company&rsquo;s then outstanding Voting Securities, except that the following
will not constitute a Change in Control: (i)&nbsp;any acquisition of securities of the Company by an Exchange Act Person from the Company
for the purpose of providing financing to the Company; (ii)&nbsp;any formation of a Group consisting solely of beneficial owners of the
Company's Voting Securities as of the effective date of this Plan; (iii)&nbsp;any repurchase or other acquisition by the Company of its
Voting Securities that causes any Exchange Act Person to become the beneficial owner of more than 50% of the Company&rsquo;s Voting Securities;
or (iv)&nbsp;with respect to any particular Participant, any acquisition of securities of the Company by the Participant, any Group including
the Participant, or any entity controlled by the Participant or a Group including the Participant. If, however, an Exchange Act Person
or Group referenced in clause (i), (ii)&nbsp;or (iii)&nbsp;above acquires beneficial ownership of additional Company Voting Securities
after initially becoming the beneficial owner of more than 50% of the combined voting power of the Company&rsquo;s Voting Securities by
one of the means described in those clauses, then a Change in Control will be deemed to have occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Individuals
who are Continuing Directors cease for any reason to constitute a majority of the members of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">A
Corporate Transaction is consummated, unless, immediately following such Corporate Transaction, all or substantially all of the individuals
and entities who were the beneficial owners of the Company's Voting Securities immediately prior to such Corporate Transaction beneficially
own, directly or indirectly, more than 50% of the combined voting power of the then outstanding Voting Securities of the surviving or
acquiring entity resulting from such Corporate Transaction (including beneficial ownership through any Parent of such entity) in substantially
the same proportions as their ownership, immediately prior to such Corporate Transaction, of the Company's Voting Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding the foregoing, to the extent that
any Award constitutes a deferral of compensation subject to Code Section&nbsp;409A or provides for a change in the time or form of payment
upon a Change in Control, then no Change in Control shall be deemed to have occurred upon an event described in this Section&nbsp;2(f)&nbsp;unless
the event would also constitute a change in ownership or effective control of, or a change in the ownership of a substantial portion of
the assets of, the Company under Code Section&nbsp;409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Code&rdquo;
means the Internal Revenue Code of 1986, as amended and in effect from time to time. For purposes of the Plan, references to sections
of the Code shall be deemed to include any applicable regulations and guidance thereunder and any successor or similar statutory provisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Committee&rdquo;
means two or more Non-Employee Directors designated by the Board to administer the Plan under Section&nbsp;3, each member of which shall
be (i)&nbsp;an independent director within the meaning of the rules&nbsp;and regulations of the Nasdaq Stock Market, and (ii)&nbsp;a non-employee
director within the meaning of Exchange Act Rule&nbsp;16b-3. Notwithstanding the foregoing, the &ldquo;Committee&rdquo; means the Board
with respect to Awards made to Non-Employee Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Company&rdquo;
means Tactile Systems Technology,&nbsp;Inc., a Delaware corporation, or any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Continuing
Director&rdquo; means an individual (i)&nbsp;who is, as of the effective date of the Plan, a director of the Company, (ii)&nbsp;who is
elected as a director of the Company subsequent to the effective date hereof pursuant to a nomination or board representation right of
preferred stockholders of the Company, or (iii)&nbsp;who becomes a director of the Company after the effective date hereof and whose initial
election, or nomination for election by the Company&rsquo;s stockholders, was approved by at least a majority of the then Continuing Directors,
but excluding, for purposes of this clause (iii), an individual whose initial assumption of office occurs as a result of an actual or
threatened proxy contest relating to the election of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Corporate
Transaction&rdquo; means (i)&nbsp;a sale or other disposition of all or substantially all of the assets of the Company, or (ii)&nbsp;a
merger, consolidation, share exchange or similar transaction involving the Company, regardless of whether the Company is the surviving
corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Disability&rdquo;
means (A)&nbsp;any permanent and total disability under any long-term disability plan or policy of the Company or its Affiliates that
covers the Participant, or (B)&nbsp;if there is no such long-term disability plan or policy, &ldquo;total and permanent disability&rdquo;
within the meaning of Code Section&nbsp;22(e)(3).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Employee&rdquo;
means an employee of the Company or an Affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Exchange
Act&rdquo; means the Securities Exchange Act of 1934, as amended and in effect from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Exchange
Act Person&rdquo; means any natural person, entity or Group other than (i)&nbsp;the Company or any Affiliate; (ii)&nbsp;any employee benefit
plan (or related trust) sponsored or maintained by the Company or any Affiliate; (iii)&nbsp;an underwriter temporarily holding securities
in connection with a registered public offering of such securities; or (iv)&nbsp;an entity whose Voting Securities are beneficially owned
by the beneficial owners of the Company&rsquo;s Voting Securities in substantially the same proportions as their beneficial ownership
of the Company&rsquo;s Voting Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Fair
Market Value&rdquo; means the fair market value of a Share determined as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
the Shares are readily tradable on an established securities market (as determined under Code Section&nbsp;409A), then Fair Market Value
will be the closing sales price for a Share on the principal securities market on which it trades on the date for which it is being determined,
or if no sale of Shares occurred on that date, on the next preceding date on which a sale of Shares occurred, as reported in <I>The Wall
Street Journal </I>or such other source as the Committee deems reliable; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
the Shares are not then readily tradable on an established securities market (as determined under Code Section&nbsp;409A), then Fair Market
Value will be determined by the Committee as the result of a reasonable application of a reasonable valuation method that satisfies the
requirements of Code Section&nbsp;409A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Full
Value Award&rdquo; means an Award other than an Option Award or Stock Appreciation Right Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Grant
Date&rdquo; means the date on which the Committee approves the grant of an Award under the Plan, or such later date as may be specified
by the Committee on the date the Committee approves the Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Group&rdquo;
means two or more persons who act, or agree to act together, as a partnership, limited partnership, syndicate or other group for the purpose
of acquiring, holding, voting or disposing of securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Non-Employee
Director&rdquo; means a member of the Board who is not an Employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Option&rdquo;
means a right granted under the Plan to purchase a specified number of Shares at a specified price. An &ldquo;Incentive Stock Option&rdquo;
or &ldquo;ISO&rdquo; means any Option designated as such and granted in accordance with the requirements of Code Section&nbsp;422. A &ldquo;Non-Qualified
Stock Option&rdquo; or &ldquo;NQSO,&rdquo; means an Option other than an Incentive Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Other
Stock-Based Award&rdquo; means an Award described in Section&nbsp;11 of this Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Parent&rdquo;
means a &ldquo;parent corporation,&rdquo; as defined in Code Section&nbsp;424(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Participant&rdquo;
means a person to whom a then-outstanding Award has been granted under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Plan&rdquo;
means this Tactile Systems Technology,&nbsp;Inc. 2025 Equity Incentive Plan, as amended and in effect from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Prior
Plan&rdquo; mans the Tactile Systems Technology,&nbsp;Inc. 2016 Equity Incentive Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Restricted
Stock&rdquo; means Shares issued to a Participant that are subject to such restrictions on transfer, vesting conditions and other restrictions
or limitations as may be set forth in this Plan and the applicable Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Service&rdquo;
means the provision of services by a Participant to the Company or any Affiliate in any Service Provider capacity. A Service Provider&rsquo;s
Service shall be deemed to have terminated either upon an actual cessation of providing services to the Company or any Affiliate or upon
the entity to which the Service Provider provides services ceasing to be an Affiliate. Except as otherwise provided in this Plan or any
Agreement, Service shall not be deemed terminated in the case of (i)&nbsp;any approved leave of absence; (ii)&nbsp;transfers among the
Company and any Affiliates in any Service Provider capacity; or (iii)&nbsp;any change in status so long as the individual remains in the
service of the Company or any Affiliate in any Service Provider capacity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Service
Provider&rdquo; means an Employee, a Non-Employee Director, or any consultant or advisor who is a natural person and who provides services
(other than in connection with (i)&nbsp;a capital-raising transaction or (ii)&nbsp;promoting or maintaining a market in Company securities)
to the Company or any Affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Share&rdquo;
means a share of Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Stock&rdquo;
means the common stock, $0.001 par value per share, of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Stock
Appreciation Right&rdquo; or &ldquo;SAR&rdquo; means the right to receive, in cash and/or Shares as determined by the Committee, an amount
equal to the appreciation in value of a specified number of Shares between the Grant Date of the SAR and its exercise date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Stock
Unit&rdquo; means a right to receive, in cash and/or Shares as determined by the Committee, the Fair Market Value of a Share, subject
to such restrictions on transfer, vesting conditions and other restrictions or limitations as may be set forth in this Plan and the applicable
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Subsidiary&rdquo;
means a &ldquo;subsidiary corporation,&rdquo; as defined in Code Section&nbsp;424(f), of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Substitute
Award&rdquo; means an Award granted upon the assumption of, or in substitution or exchange for, outstanding awards granted by a company
or other entity acquired by the Company or any Affiliate or with which the Company or any Affiliate combines. The terms and conditions
of a Substitute Award may vary from the terms and conditions set forth in the Plan to the extent that the Committee at the time of the
grant may deem appropriate to conform, in whole or in part, to the provisions of the award in substitution for which it has been granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&ldquo;Voting
Securities&rdquo; of an entity means the outstanding equity securities (or comparable equity interests) entitled to vote generally in
the election of directors of such entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Administration
of the Plan</U>.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Administration</U>.
The authority to control and manage the operations and administration of the Plan shall be vested in the Committee in accordance with
this Section&nbsp;3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Scope
of Authority</U>. Subject to the terms of the Plan, the Committee shall have the authority, in its discretion, to take such actions as
it deems necessary or advisable to administer the Plan, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">determining
the Service Providers to whom Awards will be granted, the timing of each such Award, the types of Awards and the number of Shares covered
by each Award, the terms, conditions, performance criteria, restrictions and other provisions of Awards, including the terms of the form
of Award Agreement applicable to the Awards, and the manner in which Awards are paid or settled;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">cancelling
or suspending an Award, accelerating the vesting or extending the exercise period of an Award, or otherwise amending the terms and conditions
of any outstanding Award, subject to the requirements of Sections 15(d)&nbsp;and 15(e);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">adopting
sub-plans or special provisions applicable to Awards, establishing, amending or rescinding rules&nbsp;to administer the Plan, interpreting
the Plan and any Award or Agreement, reconciling any inconsistency, correcting any defect or supplying any omission in the Plan or any
Agreement, and making all other determinations necessary or desirable for the administration of the Plan;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">granting
Substitute Awards under the Plan;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">taking
such actions as are provided in Section&nbsp;3(c)&nbsp;with respect to Awards to foreign Service Providers; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">requiring
or permitting the deferral of the settlement of an Award, and establishing the terms and conditions of any such deferral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Awards
to Foreign Service Providers</U>. The Committee may grant Awards to Service Providers who are foreign nationals, who are located outside
of the United States or who are not compensated from a payroll maintained in the United States, or who are otherwise subject to (or could
cause the Company to be subject to) legal or regulatory requirements of countries outside of the United States, on such terms and conditions
different from those specified in the Plan as may, in the judgment of the Committee, be necessary or desirable to comply with applicable
foreign laws and regulatory requirements and to promote achievement of the purposes of the Plan. In connection therewith, the Committee
may establish such subplans and modify exercise procedures and other Plan rules&nbsp;and procedures to the extent such actions are deemed
necessary or desirable, and may take any other action that it deems advisable to obtain local regulatory approvals or to comply with any
necessary local governmental regulatory exemptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Acts
of the Committee; Delegation</U>. A majority of the members of the Committee shall constitute a quorum for any meeting of the Committee,
and any act of a majority of the members present at any meeting at which a quorum is present or any act unanimously approved in writing
by all members of the Committee shall be the act of the Committee. Any such action of the Committee shall be valid and effective even
if the members of the Committee at the time of such action are later determined not to have satisfied all of the criteria for membership
in clauses (i), (ii)&nbsp;and (iii)&nbsp;of Section&nbsp;2(h). To the extent not inconsistent with applicable law or stock exchange rules,
the Committee may delegate all or any portion of its authority under the Plan to any one or more of its members or, as to Awards to Participants
who are not subject to Section&nbsp;16 of the Exchange Act, to one or more directors or executive officers of the Company or to a committee
of the Board comprised of one or more directors of the Company. The Committee may also delegate non-discretionary administrative responsibilities
in connection with the Plan to such other persons as it deems advisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Finality
of Decisions</U>. The Committee&rsquo;s interpretation of the Plan and of any Award or Agreement made under the Plan and all related decisions
or resolutions of the Board or Committee shall be made in the Committee or the Board&rsquo;s discretion and shall be final and binding
on all parties with an interest therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Indemnification</U>.
Each person who is or has been a member of the Committee or of the Board, and any other person to whom the Committee delegates authority
under the Plan, shall be indemnified by the Company, to the maximum extent permitted by law, against liabilities and expenses imposed
upon or reasonably incurred by such person in connection with or resulting from any claims against such person by reason of the performance
of the individual's duties under the Plan. This right to indemnification is conditioned upon such person providing the Company an opportunity,
at the Company&rsquo;s expense, to handle and defend the claims before such person undertakes to handle and defend them on such person&rsquo;s
own behalf. The Company will not be required to indemnify any person for any amount paid in settlement of a claim unless the Company has
first consented in writing to the settlement. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification
to which such person or persons may be entitled under the Company&rsquo;s Certificate of Incorporation or Bylaws, as a matter of law,
or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Shares
Available Under the Plan</U>.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Maximum
Shares Available</U>. Subject to the provisions of this Section&nbsp;4 and to adjustment as provided in Section&nbsp;12(a), the number
of Shares that may be the subject of Awards and issued under the Plan shall be 1,850,000, plus any Shares subject to outstanding awards
under the Prior Plan on the effective date of this Plan as described in Section&nbsp;4(b). No further awards may be made under the Prior
Plan after the effective date of this Plan. Shares issued under the Plan may come from authorized and unissued shares or treasury shares.
In determining the number of Shares to be counted against this share reserve in connection with any Award, the following rules&nbsp;shall
apply:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Where
the number of Shares subject to an Award is variable on the Grant Date, the number of Shares to be counted against the share reserve shall
be the maximum number of Shares that could be received under that particular Award, until such time as it can be determined that only
a lesser number of shares could be received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Where
two or more types of Awards are granted to a Participant in tandem with each other, such that the exercise of one type of Award with respect
to a number of Shares cancels at least an equal number of Shares of the other, the number of Shares to be counted against the share reserve
shall be the largest number of Shares that would be counted against the share reserve under either of the Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Shares
subject to Substitute Awards shall not be counted against the share reserve, nor shall they reduce the Shares authorized for grant to
a Participant in any calendar year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Awards
that will be settled solely in cash shall not be counted against the share reserve, nor shall they reduce the Shares authorized for grant
to a Participant in any calendar year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Effect
of Forfeitures and Other Actions</U>. Any Shares subject to an Award, or to an award granted under the Prior Plan that is outstanding
on the effective date of this Plan (a &ldquo;Prior Plan Award&rdquo;), that expires, is cancelled or forfeited, is settled for cash or
otherwise does not result in the issuance of all of the Shares subject to such Award shall, to the extent of such cancellation, forfeiture,
expiration, cash settlement or non-issuance, again become available for Awards under this Plan, and the share reserve under Section&nbsp;4(a)&nbsp;shall
be correspondingly replenished. The following shares shall not, however, again become available for Awards or replenish the share reserve
under Section&nbsp;4(a): (i)&nbsp;Shares tendered (either actually or by attestation) by the Participant or withheld by the Company in
payment of the exercise price of a stock option issued under this Plan or the Prior Plan, (ii)&nbsp;Shares tendered (either actually or
by attestation) by the Participant or withheld by the Company to satisfy any tax withholding obligation with respect to an award under
this Plan or the Prior Plan, (iii)&nbsp;Shares repurchased by the Company with proceeds received from the exercise of a stock option issued
under this Plan or the Prior Plan, and (iv)&nbsp;Shares subject to a stock appreciation right award issued under this Plan or the Prior
Plan that are not issued in connection with the stock settlement of that award upon its exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Effect
of Plans Operated by Acquired Companies</U>. If a company acquired by the Company or any Subsidiary or with which the Company or any Subsidiary
combines has shares available under a pre-existing plan approved by its stockholders and not adopted in contemplation of such acquisition
or combination, the shares available for grant pursuant to the terms of such pre-existing plan (as adjusted, to the extent appropriate,
using the exchange ratio or other adjustment or valuation ratio or formula used in such acquisition or combination to determine the consideration
payable to the holders of common stock of the entities party to such acquisition or combination) may be used for Awards under the Plan
and shall supplement the Share reserve under Section&nbsp;4(a). Awards using such available shares shall not be made after the date awards
or grants could have been made under the terms of the pre-existing plan absent the acquisition or combination, and shall only be made
to individuals who were not Employees or Non-Employee Directors prior to such acquisition or combination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Fractional Shares</U>. Unless otherwise determined by the Committee, the number of Shares subject to an Award shall always be a whole
number. No fractional Shares may be issued under the Plan, but the Committee may, in its discretion, pay cash in lieu of any fractional
Share in settlement of an Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Limit
on Awards to Non-Employee Directors</U>. The aggregate grant date fair value (as determined in accordance with generally accepted accounting
principles applicable in the United States) of all Awards granted during any calendar year to any Non-Employee Director (excluding any
Awards granted at the election of a Non-Employee Director in lieu of all or any portion of retainers or fees paid to Non-Employee Directors
in cash) shall not exceed $750,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Eligibility</U>.</FONT></B><FONT STYLE="font-size: 10pt">
Participation in the Plan is limited to Service Providers. Incentive Stock Options may only be granted to Employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>General
Terms of Awards</U>.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Award
Agreement</U>. Except for any Award that involves only the immediate issuance of unrestricted Shares, each Award shall be evidenced by
an Agreement setting forth the amount of the Award together with such other terms and conditions applicable to the Award (and not inconsistent
with the Plan) as determined by the Committee. An Award to a Participant may be made singly or in combination with any form of Award.
Two types of Awards may be made in tandem with each other such that the exercise of one type of Award with respect to a number of Shares
reduces the number of Shares subject to the related Award by at least an equal amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Vesting
and Term</U>. Each Agreement shall set forth the period until the applicable Award is scheduled to expire (which shall not be more than
ten years from the Grant Date), and the applicable vesting conditions and any applicable performance period. The Committee may provide
in an Agreement for such vesting conditions and timing as it may determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Transferability</U>.
Except as provided in this Section&nbsp;6(c), (i)&nbsp;during the lifetime of a Participant, only the Participant or the Participant&rsquo;s
guardian or legal representative may exercise an Option or SAR, or receive payment with respect to any other Award; and (ii)&nbsp;no Award
may be sold, assigned, transferred, exchanged or encumbered, voluntarily or involuntarily, other than by will or the laws of descent and
distribution. Any attempted transfer in violation of this Section&nbsp;6(c)&nbsp;shall be of no effect. The Committee may, however, provide
in an Agreement or otherwise that an Award (other than an Incentive Stock Option) may be transferred pursuant to a domestic relations
order or may be transferable by gift to any &ldquo;family member&rdquo; (as defined in General Instruction A.1(a)(5)&nbsp;to Form&nbsp;S-8
under the Securities Act of 1933) of the Participant. Any Award held by a transferee shall continue to be subject to the same terms and
conditions that were applicable to that Award immediately before the transfer thereof. For purposes of any provision of the Plan relating
to notice to a Participant or to acceleration or termination of an Award upon the death or termination of Service of a Participant, the
references to &ldquo;Participant&rdquo; shall mean the original grantee of an Award and not any transferee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Designation
of Beneficiary</U>. To the extent permitted by the Committee, a Participant may designate a beneficiary or beneficiaries to exercise any
Award or receive a payment under any Award that is exercisable or payable on or after the Participant&rsquo;s death. Any such designation
shall be on a form approved by the Company and shall be effective upon its receipt by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Termination
of Service</U>. Unless otherwise provided in an applicable Agreement or another then-effective written agreement between a Participant
and the Company, and subject to Section&nbsp;12 of this Plan, if a Participant&rsquo;s Service with the Company and all of its Affiliates
terminates, the following provisions shall apply (in all cases subject to the scheduled expiration of an Option or SAR Award, as applicable):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Upon
termination of Service for Cause, all unexercised Option and SAR Awards and all unvested portions of any other outstanding Awards shall
be immediately forfeited without consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Upon
termination of Service for any other reason, all unvested and unexercisable portions of any outstanding Awards shall be immediately forfeited
without consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Upon
termination of Service for any reason other than Cause, death or Disability, the currently vested and exercisable portions of Option and
SAR Awards may be exercised for a period of three months after the date of such termination. However, if a Participant thereafter dies
during such three-month period, the vested and exercisable portions of the Option and SAR Awards may be exercised for a period of one
year after the date of such termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Upon
termination of Service due to death or Disability, the currently vested and exercisable portions of Option and SAR Awards may be exercised
for a period of one year after the date of such termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Rights
as Stockholder</U>. No Participant shall have any rights as a stockholder with respect to any Shares covered by an Award unless and until
the date the Participant becomes the holder of record of the Shares, if any, to which the Award relates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Performance-Based
Awards</U>. Any Award may be granted as a performance-based Award if the Committee establishes one or more measures of corporate, business
unit or individual performance which must be attained, and the performance period over which the specified performance is to be attained,
as a condition to the grant, vesting, exercisability, lapse of restrictions and/or settlement in cash or Shares of such Award. In connection
with any such Award, the Committee shall determine the extent to which performance measures have been attained and other applicable terms
and conditions have been satisfied, and the degree to which vesting, exercisability, lapse of restrictions and/or settlement of such Award
has been earned. The Committee shall also have the authority to modify a performance period and/or adjust or waive the achievement of
performance measures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Dividends
and Dividend Equivalents</U>. No dividends, dividend equivalents or distributions will be paid with respect to Shares subject to an Option
or SAR Award. Any dividends or distributions payable with respect to Shares that are subject to the unvested portion of a Restricted Stock
Award will be subject to the same restrictions and risk of forfeiture as the Shares to which such dividends or distributions relate. In
its discretion, the Committee may provide in an Agreement for a Stock Unit Award or an Other Stock-Based Award that the Participant will
be entitled to receive dividend equivalents, based on dividends actually declared and paid on outstanding Shares, on the units or other
Share equivalents subject to the Stock Unit Award or Other Stock-Based Award, and such dividend equivalents will be subject to the same
restrictions and risk of forfeiture as the units or other Share equivalents to which such dividend equivalents relate. The additional
terms of any such dividend equivalents will be as set forth in the applicable Agreement, including the time and form of payment and whether
such dividend equivalents will be credited with interest or deemed to be reinvested in additional units or Share equivalents. Any Shares
issued or issuable during the term of this Plan as the result of the reinvestment of dividends or the deemed reinvestment of dividend
equivalents in connection with an Award shall be counted against, and replenish upon any subsequent forfeiture, the Plan&rsquo;s share
reserve as provided in Section&nbsp;4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Deferrals
of Full Value Awards</U>. The Committee may, in its discretion, permit or require the deferral by a Participant of the issuance of Shares
or payment of cash in settlement of any Full Value Award, subject to such terms, conditions, rules&nbsp;and procedures as it may establish
or prescribe for such purpose and with the intention of complying with the applicable requirements of Code Section&nbsp;409A. The terms,
conditions, rules&nbsp;and procedures for any such deferral shall be set forth in writing in the relevant Agreement or in such other agreement,
plan or document as the Committee may determine, or some combination of such documents. The terms, conditions, rules&nbsp;and procedures
for any such deferral shall address, to the extent relevant, matters such as: (i)&nbsp;the amount of compensation that may or must be
deferred (or the method for calculating the amount); (ii)&nbsp;the permissible time(s)&nbsp;and form(s)&nbsp;of payment of deferred amounts;
(iii)&nbsp;the terms and conditions of any deferral elections by a Participant or of any deferral required by the Company; and (iv)&nbsp;the
crediting of interest or dividend equivalents on deferred amounts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Stock
Option Awards</U>.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Type
and Exercise Price</U>. The Agreement pursuant to which an Option Award is granted shall specify whether the Option is an Incentive Stock
Option or a Non-Qualified Stock Option. The exercise price at which each Share subject to an Option Award may be purchased shall be determined
by the Committee and set forth in the Agreement, and shall not be less than the Fair Market Value of a Share on the Grant Date, except
in the case of Substitute Awards (to the extent consistent with Code Section&nbsp;409A and, in the case of Incentive Stock Options, Code
Section&nbsp;424).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Payment
of Exercise Price</U>. The purchase price of the Shares with respect to which an Option Award is exercised shall be payable in full at
the time of exercise. The purchase price may be paid in cash or in such other manner as the Committee may permit, including by payment
under a broker-assisted sale and remittance program, by withholding Shares otherwise issuable to the Participant upon exercise of the
Option or by delivery to the Company of Shares (by actual delivery or attestation) already owned by the Participant (in each case, such
Shares having a Fair Market Value as of the date the Option is exercised equal to the purchase price of the Shares being purchased).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Exercisability
and Expiration</U>. Each Option Award shall be exercisable in whole or in part on the terms provided in the Agreement. No Option Award
shall be exercisable at any time after its scheduled expiration. When an Option Award is no longer exercisable, it shall be deemed to
have terminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Incentive
Stock Options</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">An
Option Award will constitute an Incentive Stock Option Award only if the Participant receiving the Option Award is an Employee, and only
to the extent that (i)&nbsp;it is so designated in the applicable Agreement and (ii)&nbsp;the aggregate Fair Market Value (determined
as of the Option Award&rsquo;s Grant Date) of the Shares with respect to which Incentive Stock Options held by the Participant first become
exercisable in any calendar year (under the Plan and all other plans of the Company and its Affiliates) does not exceed $100,000 or such
other amount specified by the Code. To the extent an Option granted to a Participant exceeds this limit, the Option shall be treated as
a Non-Qualified Stock Option. The maximum number of Shares that may be issued upon the exercise of Incentive Stock Options shall be equal
to the maximum number of Shares <FONT STYLE="background-color: white">that may be the subject of Awards and issued under the Plan as provided
in the first sentence of Section&nbsp;4(a)</FONT>, subject to adjustment as provided in Section&nbsp;12(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
Participant may receive an Incentive Stock Option Award under the Plan if, immediately after the grant of such Award, the Participant
would own (after application of the rules&nbsp;contained in Code Section&nbsp;424(d)) Shares possessing more than 10% of the total combined
voting power of all classes of stock of the Company or an Affiliate, unless (i)&nbsp;the per Share exercise price for such Award is at
least 110% of the Fair Market Value of a Share on the Grant Date and (ii)&nbsp;such Award will expire no later than five years after its
Grant Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">For
purposes of continued Service by a Participant who has been granted an Incentive Stock Option Award, no approved leave of absence may
exceed three months unless reemployment upon expiration of such leave is provided by statute or contract. If reemployment is not so provided,
then on the date six months following the first day of such leave, any Incentive Stock Option held by the Participant shall cease to be
treated as an Incentive Stock Option and shall be treated for tax purposes as a Non-Qualified Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
an Incentive Stock Option Award is exercised after the expiration of the exercise periods that apply for purposes of Code Section&nbsp;422,
such Option shall thereafter be treated as a Non-Qualified Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Agreement covering an Incentive Stock Option Award shall contain such other terms and provisions that the Committee determines necessary
to qualify the Option Award as an Incentive Stock Option Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Stock
Appreciation Right Awards</U>.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Nature
of Award</U>. An Award of Stock Appreciation Rights shall be subject to such terms and conditions as are determined by the Committee,
and shall provide a Participant the right to receive upon exercise of the SAR Award all or a portion of the excess of (i)&nbsp;the Fair
Market Value as of the date of exercise of the SAR Award of the number of Shares as to which the SAR Award is being exercised, over (ii)&nbsp;the
aggregate exercise price for such number of Shares. The per Share exercise price for any SAR Award shall be determined by the Committee
and set forth in the applicable Agreement, and shall not be less than the Fair Market Value of a Share on the Grant Date, except in the
case of Substitute Awards (to the extent consistent with Code Section&nbsp;409A).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Exercise
of SAR</U>. Each SAR Award may be exercisable in whole or in part at the times, on the terms and in the manner provided in the Agreement.
No SAR Award shall be exercisable at any time after its scheduled expiration. When a SAR Award is no longer exercisable, it shall be deemed
to have terminated. Upon exercise of a SAR Award, payment to the Participant shall be made at such time or times as shall be provided
in the Agreement in the form of cash, Shares or a combination of cash and Shares as determined by the Committee. The Agreement may provide
for a limitation upon the amount or percentage of the total appreciation on which payment (whether in cash and/or Shares) may be made
in the event of the exercise of a SAR Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Restricted
Stock Awards</U>.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Vesting
and Consideration</U>. Shares subject to a Restricted Stock Award shall be subject to vesting and the lapse of applicable restrictions
based on such conditions or factors and occurring over such period of time as the Committee may determine in its discretion. The Committee
may provide whether any consideration other than Services must be received by the Company or any Affiliate as a condition precedent to
the grant of a Restricted Stock Award, and may correspondingly provide for Company reacquisition or repurchase rights if such additional
consideration has been required and some or all of a Restricted Stock Award does not vest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Shares
Subject to Restricted Stock Awards</U>. Unvested Shares subject to a Restricted Stock Award shall be evidenced by a book-entry in the
name of the Participant with the Company&rsquo;s transfer agent or by one or more Stock certificates issued in the name of the Participant.
Any such Stock certificate shall be deposited with the Company or its designee, together with an assignment separate from the certificate,
in blank, signed by the Participant, and bear an appropriate legend referring to the restricted nature of the Restricted Stock evidenced
thereby. Any book-entry shall be subject to comparable restrictions and corresponding stop transfer instructions. Upon the vesting of
Shares of Restricted Stock, and the Company&rsquo;s determination that any necessary conditions precedent to the release of vested Shares
(such as satisfaction of tax withholding obligations and compliance with applicable legal requirements) have been satisfied, such vested
Shares shall be made available to the Participant in such manner as may be prescribed or permitted by the Committee. Except as otherwise
provided in the Plan or an applicable Agreement, a Participant with a Restricted Stock Award shall have all the rights of a shareholder,
including the right to vote the Shares of Restricted Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Stock
Unit Awards</U>.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Vesting
and Consideration</U>. A Stock Unit Award shall be subject to vesting and the lapse of applicable restrictions based on such conditions
or factors and occurring over such period of time as the Committee may determine in its discretion. If vesting of a Stock Unit Award is
conditioned on the achievement of specified performance goals, the extent to which they are achieved over the specified performance period
shall determine the number of Stock Units that will be earned and eligible to vest, which may be greater or less than the target number
of Stock Units stated in the Agreement. The Committee may provide whether any consideration other than Services must be received by the
Company or any Affiliate as a condition precedent to the settlement of a Stock Unit Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Settlement
of Award</U>. Following the vesting of a Stock Unit Award, and the Company&rsquo;s determination that any necessary conditions precedent
to the settlement of the Award (such as satisfaction of tax withholding obligations and compliance with applicable legal requirements)
have been satisfied, settlement of the Award and payment to the Participant shall be made at such time or times in the form of cash, Shares
(which may themselves be considered Restricted Stock under the Plan) or a combination of cash and Shares as determined by the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Other
Stock-Based Awards</U>.</FONT></B><FONT STYLE="font-size: 10pt"> The Committee may from time to time grant Shares and other Awards that
are valued by reference to and/or payable in whole or in part in Shares under the Plan. The Committee shall determine the terms and conditions
of such Awards, including any performance goals or conditions or the accrual of dividends or dividend equivalents, which shall be consistent
with the terms and purposes of the Plan. The Committee may direct the Company to issue Shares subject to restrictive legends and/or stop
transfer instructions that are consistent with the terms and conditions of the Award to which the Shares relate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Changes
in Capitalization, Corporate Transactions, Change in Control</U>.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Adjustments
for Changes in Capitalization</U>. In the event of any equity restructuring (within the meaning of FASB ASC Topic 718) that causes the
per share value of Shares to change, such as a stock dividend, stock split, spinoff, rights offering or recapitalization through an extraordinary
dividend, the Committee shall make such adjustments as it deems equitable and appropriate to (i)&nbsp;the aggregate number and kind of
Shares or other securities issued or reserved for issuance under the Plan, (ii)&nbsp;the number and kind of Shares or other securities
subject to outstanding Awards, (iii)&nbsp;the exercise price of outstanding Options and SARs, and (iv)&nbsp;any maximum limitations prescribed
by the Plan with respect to certain types of Awards or the grants to individuals of certain types of Awards. In the event of any other
change in corporate capitalization, including a merger, consolidation, reorganization, or partial or complete liquidation of the Company,
such equitable adjustments described in the foregoing sentence may be made as determined to be appropriate and equitable by the Committee
to prevent dilution or enlargement of rights of Participants.&nbsp; In either case, any such adjustment shall be conclusive and binding
for all purposes of the Plan.&nbsp; No adjustment shall be made pursuant to this Section&nbsp;12(a)&nbsp;in connection with the conversion
of any convertible securities of the Company, or in a manner that would cause Incentive Stock Options to violate Section&nbsp;422(b)&nbsp;of
the Code or cause an&nbsp;Award&nbsp;to be subject to adverse tax consequences&nbsp;under&nbsp;Section&nbsp;409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Corporate
Transactions</U>. Unless otherwise provided in an applicable Agreement or another written agreement between a Participant and the Company,
the following provisions shall apply to outstanding Awards in the event of a Change in Control that involves a Corporate Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I><U>Continuation,
Assumption or Replacement of Awards</U></I>. In the event of a Corporate Transaction, then the surviving or successor entity (or its Parent)
may continue, assume or replace Awards outstanding as of the date of the Corporate Transaction (with such adjustments as may be required
or permitted by Section&nbsp;12(a)), and such Awards or replacements therefor shall remain outstanding and be governed by their respective
terms, subject to Section&nbsp;12(b)(4)&nbsp;below. A surviving or successor entity may elect to continue, assume or replace only some
Awards or portions of Awards. For purposes of this Section&nbsp;12(b)(1), an Award shall be considered assumed or replaced if, in connection
with the Corporate Transaction and in a manner consistent with Code Sections 409A and 424, either (i)&nbsp;the contractual obligations
represented by the Award are expressly assumed by the surviving or successor entity (or its Parent) with appropriate adjustments to the
number and type of securities subject to the Award and the exercise price thereof that preserves the intrinsic value of the Award existing
at the time of the Corporate Transaction, or (ii)&nbsp;the Participant has received a comparable equity-based award that preserves the
intrinsic value of the Award existing at the time of the Corporate Transaction and contains terms and conditions that are substantially
similar to those of the Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I><U>Acceleration</U></I>.
If and to the extent that outstanding Awards under the Plan are not continued, assumed or replaced in connection with a Corporate Transaction,
then (i)&nbsp;all outstanding Option and SAR Awards shall become fully vested and exercisable for such period of time prior to the effective
time of the Corporate Transaction as is deemed fair and equitable by the Committee, and shall terminate at the effective time of the Corporate
Transaction, and (ii)&nbsp;all outstanding Full Value Awards shall fully vest immediately prior to the effective time of the Corporate
Transaction. The Committee shall provide written notice of the period of accelerated exercisability of Option and SAR Awards to all affected
Participants. The exercise of any Option or SAR Award whose exercisability is accelerated as provided in this Section&nbsp;12(b)(2)&nbsp;shall
be conditioned upon the consummation of the Corporate Transaction and shall be effective only immediately before such consummation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I><U>Payment
for Awards</U></I>. If and to the extent that outstanding Awards under the Plan are not continued, assumed or replaced in connection with
a Corporate Transaction, then the Committee may provide that some or all of such outstanding Awards shall be canceled at or immediately
prior to the effective time of the Corporate Transaction in exchange for payments to the holders as provided in this Section&nbsp;12(b)(3).
The Committee will not be required to treat all Awards similarly for purposes of this Section&nbsp;12(b)(3). The payment for any Award
surrendered shall be in an amount equal to the difference, if any, between (i)&nbsp;the fair market value (as determined in good faith
by the Committee) of the consideration that would otherwise be received in the Corporate Transaction for the number of Shares subject
to the Award, and (ii)&nbsp;the aggregate exercise price (if any) for the Shares subject to such Award. If the amount determined pursuant
to clause (i)&nbsp;of the preceding sentence is less than or equal to the amount determined pursuant to clause (ii)&nbsp;of the preceding
sentence with respect to any Award, such Award may be canceled pursuant to this Section&nbsp;12(b)(3)&nbsp;without payment of any kind
to the affected Participant. Payment of any amount under this Section&nbsp;12(b)(3)&nbsp;shall be made in such form, on such terms and
subject to such conditions as the Committee determines in its discretion, which may or may not be the same as the form, terms and conditions
applicable to payments to the Company&rsquo;s stockholders in connection with the Corporate Transaction, and may, in the Committee&rsquo;s
discretion, include subjecting such payments to vesting conditions comparable to those of the Award surrendered, subjecting such payments
to escrow or holdback terms comparable to those imposed upon the Company&rsquo;s stockholders under the Corporate Transaction, or calculating
and paying the present value of payments that would otherwise be subject to escrow or holdback terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I><U>Termination
After a Corporate Transaction</U></I>. If and to the extent that Awards are continued, assumed or replaced under the circumstances described
in Section&nbsp;12(b)(1), and if within twelve months after the Corporate Transaction a Participant experiences an involuntary termination
of Service for reasons other than Cause, then (i)&nbsp;outstanding Options and SARs issued to the Participant that are not yet fully exercisable
shall immediately become exercisable in full and shall remain exercisable for one year following the Participant&rsquo;s termination of
Service, and (ii)&nbsp;any Full Value Awards that are not yet fully vested shall immediately vest in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Other
Change in Control</U>. Unless otherwise provided in an applicable Agreement or another written agreement between a Participant and the
Company, in the event of a Change in Control that does not involve a Corporate Transaction, all Awards will continue in accordance with
their terms; provided, however, if within twelve months after the Change in Control a Participant experiences an involuntary termination
of Service for reasons other than Cause, then (i)&nbsp;outstanding Options and SARs issued to the Participant that are not yet fully exercisable
shall immediately become exercisable in full and shall remain exercisable for one year following the Participant&rsquo;s termination of
Service, and (ii)&nbsp;any Full Value Awards that are not yet fully vested shall immediately vest in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Dissolution
or Liquidation</U>. Unless otherwise provided in an applicable Agreement, in the event of a proposed dissolution or liquidation of the
Company, the Committee will notify each Participant as soon as practicable prior to the effective date of such proposed transaction. An
Award will terminate immediately prior to the consummation of such proposed action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Plan
Participation and Service Provider Status</U>.</FONT></B><FONT STYLE="font-size: 10pt"> Status as a Service Provider shall not be construed
as a commitment that any Award will be made under the Plan to that Service Provider or to eligible Service Providers generally. Nothing
in the Plan or in any Agreement or related documents shall confer upon any Service Provider or Participant any right to continued Service
with the Company or any Affiliate, nor shall it interfere with or limit in any way any right of the Company or any Affiliate to terminate
the person&rsquo;s Service at any time with or without Cause or change such person&rsquo;s compensation, other benefits, job responsibilities
or title.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Tax
Withholding</U>.</FONT></B><FONT STYLE="font-size: 10pt"> The Company or any Affiliate, as applicable, shall have the right to (i)&nbsp;withhold
from any cash payment under the Plan or any other compensation owed to a Participant an amount sufficient to cover any required withholding
taxes related to the grant, vesting, exercise or settlement of an Award, and (ii)&nbsp;require a Participant or other person receiving
Shares under the Plan to pay a cash amount sufficient to cover any required withholding taxes before actual receipt of those Shares. In
lieu of all or any part of a cash payment from a person receiving Shares under the Plan, the Committee may permit the individual to cover
all or any part of the required tax withholdings (up to the Participant&rsquo;s maximum individual statutory tax withholding rate) by
authorizing the Company to withhold a number of the Shares that would otherwise be delivered to the Participant, or by delivering to the
Company Shares already owned by the Participant, with the Shares so withheld or delivered having a Fair Market Value on the date the taxes
are required to be withheld equal to the amount of taxes to be withheld.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Effective
Date, Duration, Amendment and Termination of the Plan</U>.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Effective
Date</U>. The Plan shall become effective on the date it is approved by the Company&rsquo;s stockholders, which shall be considered the
date of its adoption for purposes of Treasury Regulation &sect;1.422-2(b)(2)(i). No Awards shall be made under the Plan prior to its effective
date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Duration
of the Plan</U>. The Plan shall remain in effect until all Shares subject to it are distributed, all Awards have expired or terminated,
the Plan is terminated pursuant to Section&nbsp;15(c), or the tenth anniversary of the effective date of the Plan, whichever occurs first
(the &ldquo;Termination Date&rdquo;). Awards made before the Termination Date shall continue to be outstanding in accordance with their
terms and the terms of the Plan unless otherwise provided in the applicable Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Amendment
and Termination of the Plan</U>. The Board may at any time terminate, suspend or amend the Plan. The Company shall submit any amendment
of the Plan to its stockholders for approval only to the extent required by applicable laws or regulations or the rules&nbsp;of any securities
exchange on which the Shares may then be listed. No termination, suspension, or amendment of the Plan may materially impair the rights
of any Participant under a previously granted Award without the Participant's consent, unless such action is necessary to comply with
applicable law or stock exchange rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Amendment
of Awards</U>. Subject to Section&nbsp;15(e), the Committee may unilaterally amend the terms of any Agreement evidencing an Award previously
granted, except that no such amendment may materially impair the rights of any Participant under the applicable Award without the Participant's
consent, unless such amendment is necessary to comply with applicable law or stock exchange rules&nbsp;or any compensation recovery policy
as provided in Section&nbsp;16(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Option or SAR Repricing</U>. Except as provided in Section&nbsp;12(a), no Option or Stock Appreciation Right Award granted under the Plan
may be (i)&nbsp;amended to decrease the exercise price thereof, (ii)&nbsp;cancelled in conjunction with the grant of any new Option or
Stock Appreciation Right Award with a lower exercise price, (iii)&nbsp;cancelled in exchange for cash, other property or the grant of
any Full Value Award at a time when the per share exercise price of the Option or Stock Appreciation Right Award is greater than the current
Fair Market Value of a Share, or (iv)&nbsp;otherwise subject to any action that would be treated under accounting rules&nbsp;as a &ldquo;repricing&rdquo;
of such Option or Stock Appreciation Right Award, unless such action is first approved by the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16.</B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Other
Provisions</U>.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Unfunded
Plan</U>. The Plan shall be unfunded and the Company shall not be required to segregate any assets that may at any time be represented
by Awards under the Plan. Neither the Company, its Affiliates, the Committee, nor the Board shall be deemed to be a trustee of any amounts
to be paid under the Plan nor shall anything contained in the Plan or any action taken pursuant to its provisions create or be construed
to create a fiduciary relationship between the Company and/or its Affiliates, and a Participant. To the extent any person has or acquires
a right to receive a payment in connection with an Award under the Plan, this right shall be no greater than the right of an unsecured
general creditor of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Limits
of Liability</U>. Except as may be required by law, neither the Company nor any member of the Board or of the Committee, nor any other
person participating (including participation pursuant to a delegation of authority under Section&nbsp;3(c)&nbsp;of the Plan) in any determination
of any question under the Plan, or in the interpretation, administration or application of the Plan, shall have any liability to any party
for any action taken, or not taken, in good faith under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Compliance
with Applicable Legal Requirements and Company Policies</U>. No Shares distributable pursuant to the Plan shall be issued and delivered
unless and until the issuance of the Shares complies with all applicable legal requirements, including compliance with the provisions
of applicable state and federal securities laws, and the requirements of any securities exchanges on which the Company&rsquo;s Shares
may, at the time, be listed. During any period in which the offering and issuance of Shares under the Plan is not registered under federal
or state securities laws, Participants shall acknowledge that they are acquiring Shares under the Plan for investment purposes and not
for resale, and that Shares may not be transferred except pursuant to an effective registration statement under, or an exemption from
the registration requirements of, such securities laws.&nbsp; Any stock certificate or book-entry evidencing Shares issued under the Plan
that are subject to securities law restrictions shall bear or be accompanied by an appropriate restrictive legend or stop transfer instruction.
Notwithstanding any other provision of this Plan, the acquisition, holding or disposition of Shares acquired pursuant to the Plan shall
in all events be subject to compliance with applicable Company policies, including those relating to insider trading, pledging or hedging
transactions, stock ownership guidelines, and post-vesting holding periods, and to forfeiture or recovery of compensation as provided
in Section&nbsp;16(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Other
Benefit and Compensation Programs</U>. Payments and other benefits received by a Participant under an Award made pursuant to the Plan
shall not be deemed a part of a Participant&rsquo;s regular, recurring compensation for purposes of the termination, indemnity or severance
pay laws of any country and shall not be included in, nor have any effect on, the determination of benefits under any other employee benefit
plan, contract or similar arrangement provided by the Company or an Affiliate unless expressly so provided by such other plan, contract
or arrangement, or unless the Committee expressly determines that an Award or portion of an Award should be included to accurately reflect
competitive compensation practices or to recognize that an Award has been made in lieu of a portion of competitive cash compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Governing
Law</U>. To the extent that federal laws do not otherwise control, the Plan and all determinations made and actions taken pursuant to
the Plan shall be governed by the laws of the State of Delaware without regard to its conflicts-of-law principles and shall be construed
accordingly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Severability</U>.
If any provision of the Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining
parts of the Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Code
Section&nbsp;409A</U>. It is intended that (i)&nbsp;all Awards of Options, SARs and Restricted Stock under the Plan will not provide for
the deferral of compensation within the meaning of Code Section&nbsp;409A and thereby be exempt from Code Section&nbsp;409A, and (ii)&nbsp;all
other Awards under the Plan will either not provide for the deferral of compensation within the meaning of Code Section&nbsp;409A, or
will comply with the requirements of Code Section&nbsp;409A, and Awards shall be structured and the Plan administered and interpreted
in accordance with this intent. The Plan and any Agreement may be unilaterally amended by the Company in any manner deemed necessary or
advisable by the Committee or Board in order to maintain such exemption from or compliance with Code Section&nbsp;409A, and any such amendment
shall conclusively be presumed to be necessary to comply with applicable law. Notwithstanding anything to the contrary in the Plan or
any Agreement, with respect to any Award that constitutes a deferral of compensation subject to Code Section&nbsp;409A:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
any amount is payable under such Award upon a termination of Service, a termination of Service will be deemed to have occurred only at
such time as the Participant has experienced a &ldquo;separation from service&rdquo; as such term is defined for purposes of Code Section&nbsp;409A;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
any amount shall be payable with respect to any such Award as a result of a Participant&rsquo;s &ldquo;separation from service&rdquo;
at such time as the Participant is a &ldquo;specified employee&rdquo; within the meaning of Code Section&nbsp;409A, then no payment shall
be made, except as permitted under Code Section&nbsp;409A, prior to the first business day after the earlier of (i)&nbsp;the date that
is six months after the Participant&rsquo;s separation from service or (ii)&nbsp;the Participant&rsquo;s death. Unless the Committee has
adopted a specified employee identification policy as contemplated by Code Section&nbsp;409A, specified employees will be identified in
accordance with the default provisions specified under Code Section&nbsp;409A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None of the Company, the Board, the Committee
nor any other person involved with the administration of this Plan shall (i)&nbsp;in any way be responsible for ensuring the exemption
of any Award from, or compliance by any Award with, the requirements of Code Section&nbsp;409A, (ii)&nbsp;have any obligation to design
or administer the Plan or Awards granted thereunder in a manner that minimizes a Participant&rsquo;s tax liabilities, including the avoidance
of any additional tax liabilities under Code Section&nbsp;409A, and (iii)&nbsp;shall have any liability to any Participant for any such
tax liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Forfeiture
and Compensation Recovery</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Committee may specify in an Agreement that the Participant&rsquo;s rights, payments, and benefits with respect to an Award will be subject
to reduction, cancellation, forfeiture or recovery by the Company upon the occurrence of certain specified events, in addition to any
otherwise applicable vesting or performance conditions of an Award. Such events may include, without limitation, termination of Service
for Cause; violation of any material Company or Affiliate policy; breach of noncompetition, non-solicitation or confidentiality provisions
that apply to the Participant; a determination that the payment of the Award was based on an incorrect determination that financial or
other criteria were met or other conduct by the Participant that is detrimental to the business or reputation of the Company or its Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Awards
and any compensation associated therewith are subject to forfeiture, recovery by the Company or other action pursuant to any compensation
recovery policy adopted by the Board or the Committee at any time, as amended from time to time, which includes but is not limited to
any compensation recovery policy adopted by the Board or the Committee in response to the requirements of Section&nbsp;10D of the Exchange
Act, the SEC&rsquo;s final rules&nbsp;thereunder, and applicable listing rules&nbsp;or other rules&nbsp;and regulations implementing the
foregoing or as otherwise required by law or stock exchange. Any Agreement will be automatically unilaterally amended to comply with any
such compensation recovery policy and all Participants subject to such policy or regulations by accepting any Award shall be deemed to
have consented to the inclusion of such forfeiture and recovery provisions in his or her Award Agreement, as determined by the Committee
to be necessary or appropriate to comply with such policy and applicable regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>tm2514641d1_10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>TACTILE SYSTEMS TECHNOLOGY,
INC. <BR>
2025 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Restricted Stock Unit Award Agreement</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>&nbsp;</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">Tactile Systems
Technology, Inc. (the &ldquo;Company&rdquo;), pursuant to its 2025 Equity Incentive Plan (the &ldquo;Plan&rdquo;), hereby grants an award
of Restricted Stock Units to you, the Participant named below. The terms and conditions of this Award are set forth in this Restricted
Stock Unit Award Agreement (the &ldquo;Agreement&rdquo;), consisting of this cover page and the Terms and Conditions on the following
pages, and in the Plan document, a copy of which has been provided to you. Any capitalized term that is not defined in this Agreement
shall have the meaning set forth in the Plan as it currently exists or as it is amended in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Name:
</B></FONT>/$ParticipantName$/</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>Grant Date: </B>/$GrantDate$/</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Number
of Restricted Stock Units</B></FONT>: /$AwardsGranted$/</P>

<P STYLE="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>Vesting Schedule:</B></P>

<P STYLE="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">/$VestingSchedule$/</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">By signing below or otherwise evidencing your acceptance
of this Agreement in a manner approved by the Company, you agree to all of the terms and conditions contained in this Agreement and in
the Plan document. You acknowledge that you have received and reviewed these documents and that they set forth the entire agreement between
you and the Company regarding the grant to you of the number of Restricted Stock Units specified in the table above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.7in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 382.15pt 0pt 69.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 382.15pt 0pt 69.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><B>Chief Executive Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Tactile Systems Technology,&nbsp;Inc.<BR>
2025 Equity Incentive Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Restricted Stock Unit Award Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>Terms and Conditions</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>1.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Grant
of Restricted Stock Units</U></FONT></B><FONT STYLE="font-size: 10pt">. The Company hereby confirms the grant to you, as of the Grant
Date and subject to the terms and conditions in this Agreement and the Plan, of the number of Restricted Stock Units specified on the
cover page&nbsp;of this Agreement (the &ldquo;Units&rdquo;). Each Unit represents the right to receive one Share of the Company&rsquo;s
common stock. The Units granted to you will be credited to an account in your name maintained by the Company. This account shall be unfunded
and maintained for book-keeping purposes only, with the Units simply representing an unfunded and unsecured obligation of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>2.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Restrictions
Applicable to Units</U></FONT></B><FONT STYLE="font-size: 10pt">. Neither this Award nor the Units subject to this Award may be sold,
assigned, transferred, exchanged or encumbered other than by will or the laws of descent and distribution. Any attempted transfer in
violation of this Section&nbsp;2 shall be of no effect and shall result in the forfeiture of all Units. The Units and your right to receive
Shares in settlement of the Units under this Agreement shall be subject to forfeiture as provided in Section&nbsp;4 until satisfaction
of the vesting conditions set forth in Section&nbsp;3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>3.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Vesting
of Units</U></FONT></B><FONT STYLE="font-size: 10pt">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>(a)</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Scheduled
Vesting</U>. If you remain a Service Provider continuously from the Grant Date specified on the cover page&nbsp;of this Agreement (subject
to Section&nbsp;3(b)), then the Units will vest in the numbers and on the dates specified in the Vesting Schedule on the cover page&nbsp;of
this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>(b)</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Accelerated
Vesting</U>. Notwithstanding Section&nbsp;3(a):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(1)</I></FONT><I>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Death
or Disability</FONT></I><FONT STYLE="font-size: 10pt">. If your Service terminates prior to the final scheduled vesting date due to your
death or Disability, all of the unvested Units shall vest as of such termination date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(2)</I></FONT><I>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Change
in Control</FONT></I><FONT STYLE="font-size: 10pt">. If and to the extent this Award is continued, assumed or replaced in connection with
a Change in Control, and if within one year after the Change in Control you experience an involuntary termination of Service for reasons
other than Cause, or you terminate your Service for Good Reason (as defined below), then all of the unvested Units shall vest as of such
termination date. In addition, vesting of the Units may be accelerated during the term of the Award under the circumstances described
in Sections 12(b)&nbsp;and 12(c)&nbsp;of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(3)</I></FONT><I>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Definition
of &ldquo;Good Reason</FONT></I><FONT STYLE="font-size: 10pt">.&rdquo; &ldquo;Good Reason&rdquo; shall, if you have an employment agreement
with the Company, have the meaning set forth in your employment agreement. If you do not have an employment agreement with the Company,
 &ldquo;Good Reason&rdquo; means the existence of one or more of the following conditions without your written consent, so long as you
provided written notice to the Company of the existence of the condition not later than 90 days after the initial existence of the condition,
the condition has not been remedied by the Company within 30 days after its receipt of such notice and your Service terminates no later
than 130 days after the condition&rsquo;s initial occurrence: (i)&nbsp;any material, adverse change in your duties, responsibilities,
or authority; (ii)&nbsp;a material reduction in your base salary or bonus opportunity that is not part of a general reduction applicable
to employees in the same classification or grade as you; or (iii)&nbsp;a geographical relocation of your principal office location by
more than 50 miles.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(4)</I></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Other
Agreements or Plans. </I>Unvested Units shall also vest as provided in any separate employment (or similar) agreement or severance plan
to which you are a party or a participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>4.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Effect
of Termination of Service</U></FONT></B><FONT STYLE="font-size: 10pt">. Except as otherwise provided in accordance with Section&nbsp;3(b),
if you cease to be a Service Provider, you will forfeit all unvested Units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>5.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Settlement
of Units</U></FONT></B><FONT STYLE="font-size: 10pt">. After any Units vest pursuant to Section&nbsp;3, the Company shall, as soon as
practicable (but no later than March&nbsp;15 of the year following the calendar year in which such Units vest), cause to be issued and
delivered to you, or to your designated beneficiary or estate in the event of your death, one Share in payment and settlement of each
vested Unit. Delivery of the Shares shall be effected by the issuance of a stock certificate to you, by an appropriate entry in the stock
register maintained by the Company&rsquo;s transfer agent with a notice of issuance provided to you, or by the electronic delivery of
the Shares to a brokerage account you designate, and shall be subject to the tax withholding provisions of Section&nbsp;6 and compliance
with all applicable legal requirements as provided in Section&nbsp;16(c)&nbsp;of the Plan, and shall be in complete satisfaction and
settlement of such vested Units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>6.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Tax
Consequences and Withholding</U></FONT></B><FONT STYLE="font-size: 10pt">. No Shares will be delivered to you in settlement of vested
Units unless you have made arrangements acceptable to the Company for payment of any federal, state, local or foreign withholding taxes
that may be due as a result of the delivery of the Shares. You hereby authorize the Company (or any Affiliate) to withhold from payroll
or other amounts payable to you any sums required to satisfy such withholding tax obligations, and otherwise agree to satisfy such obligations
in accordance with the provisions of Section&nbsp;14 of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>7.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Shareholder Rights</U></FONT></B><FONT STYLE="font-size: 10pt">. The Units subject to this Award do not entitle you to any rights of
a shareholder of the Company&rsquo;s common stock. You will not have any of the rights of a shareholder of the Company in connection
with the grant of Units subject to this Agreement unless and until Shares are issued to you upon settlement of the Units as provided
in Section&nbsp;5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>8.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Governing
Plan Document</U></FONT></B><FONT STYLE="font-size: 10pt">. This Agreement and the Award are subject to all the provisions of the Plan,
and to all interpretations, rules&nbsp;and regulations which may, from time to time, be adopted and promulgated by the Committee pursuant
to the Plan. If there is any conflict between the provisions of this Agreement and the Plan, the provisions of the Plan will govern.
If there is any conflict between this Agreement or the Plan and any separate employment (or similar) agreement or severance plan to which
you are a party or a participant, the provisions of the other agreement or plan will govern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>9.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Choice
of Law</U></FONT></B><FONT STYLE="font-size: 10pt">. This Agreement will be interpreted and enforced under the laws of the state of Delaware
(without regard to its conflicts or choice of law principles).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>10.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Binding
Effect</U></FONT></B><FONT STYLE="font-size: 10pt">. This Agreement will be binding in all respects on your heirs, representatives, successors
and assigns, and on the successors and assigns of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>11.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Section&nbsp;409A
of the Code</U></FONT></B><FONT STYLE="font-size: 10pt">. The award of Units as provided in this Agreement and any issuance of Shares
or payment pursuant to this Agreement are intended to be exempt from Section&nbsp;409A of the Code under the short-term deferral exception
specified in Treas. Reg. &sect; 1.409A-l(b)(4).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>12.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Compensation
Recovery Policy</U></FONT></B><FONT STYLE="font-size: 10pt">. All compensation paid or payable pursuant to this Agreement shall be subject
to potential forfeiture or recovery by the Company in accordance with any compensation recovery policy adopted by the Board or any committee
thereof, including but not limited to in response to the requirements of Section&nbsp;10D of the Exchange Act and any implementing rules&nbsp;and
regulations thereunder adopted by the Securities and Exchange Commission or any national securities exchange on which the Company&rsquo;s
common stock is then listed. This Agreement will be automatically amended to comply with any such compensation recovery policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>13.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Other
Agreements</U>. </FONT></B><FONT STYLE="font-size: 10pt">You agree that in connection with the settlement of vested Units, you will execute
such documents as may be necessary to become a party to any stockholder, voting or similar agreements as the Company may require.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>14.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Restrictive
Legends</U>. </FONT></B><FONT STYLE="font-size: 10pt">The Company may place a legend or legends on any certificate representing Shares
issued in settlement of vested Units summarizing transfer and other restrictions to which the Shares may be subject under applicable
securities laws, other provisions of this Agreement, or other agreements contemplated by Section&nbsp;13 of this Agreement. You agree
that in order to ensure compliance with the restrictions referred to in this Agreement, the Company may issue appropriate &ldquo;stop
transfer&rdquo; instructions to its transfer agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>15.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>&#8239;<FONT STYLE="font-size: 10pt">Electronic
Delivery and Acceptance</FONT></U></B><FONT STYLE="font-size: 10pt">. The Company may deliver any documents related to<BR>
this Restricted Stock Unit Award by electronic means and request your acceptance of this Agreement by electronic means. You hereby consent
to receive all applicable documentation by electronic delivery and to participate in the Plan through an on-line (and/or voice activated)
system established and maintained by the Company or the Company&rsquo;s third-party stock plan administrator.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><B><I>By signing the cover page&nbsp;of
this Agreement or otherwise accepting this Agreement in a manner approved by the Company, you agree to all the terms and conditions described
above and in the Plan document.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>tm2514641d1_10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">$CurrentDate$/</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.<BR>
2025 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Restricted Stock Unit Award Agreement (Director)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Tactile Systems Technology,&nbsp;Inc.
(the &ldquo;Company&rdquo;), pursuant to its 2025 Equity Incentive Plan (the &ldquo;Plan&rdquo;), hereby grants an award of Restricted
Stock Units to you, the Participant named below. The terms and conditions of this Award are set forth in this Restricted Stock Unit Award
Agreement (the &ldquo;Agreement&rdquo;), consisting of this cover page&nbsp;and the Terms and Conditions on the following pages, and in
the Plan document, a copy of which has been provided to you. Any capitalized term that is not defined in this Agreement shall have the
meaning set forth in the Plan as it currently exists or as it is amended in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Name: </B></FONT>/$ParticipantName$/</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Grant Date:
</B></FONT>/$GrantDate$/</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Number
of Restricted Stock Units: </B></FONT>/$AwardsGranted$/&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><B>Vesting Schedule:</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100% of the Units will vest on the earlier of a) the first anniversary of the Grant Date or (b) the next annual meeting of stockholders
following the Grant Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By signing below or otherwise
evidencing your acceptance of this Agreement in a manner approved by the Company, you agree to all of the terms and conditions contained
in this Agreement and in the Plan document. You acknowledge that you have received and reviewed these documents and that they set forth
the entire agreement between you and the Company regarding the grant to you of the number of Restricted Stock Units specified above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>TACTILE SYSTEMS TECHNOLOGY, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Chief Executive Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tactile Systems Technology,&nbsp;Inc.<BR>
2025 Equity Incentive Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Restricted Stock Unit Award Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Terms
and Conditions</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>1.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Grant
of Restricted Stock Units</U></FONT></B><FONT STYLE="font-size: 10pt">. The Company hereby confirms the grant to you, as of the Grant
Date and subject to the terms and conditions in this Agreement and the Plan, of the number of Restricted Stock Units specified on the
cover page&nbsp;of this Agreement (the &ldquo;Units&rdquo;). Each Unit represents the right to receive one Share of the Company&rsquo;s
common stock. The Units granted to you will be credited to an account in your name maintained by the Company. This account shall be unfunded
and maintained for book-keeping purposes only, with the Units simply representing an unfunded and unsecured obligation of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>2.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Restrictions
Applicable to Units</U></FONT></B><FONT STYLE="font-size: 10pt">. Neither this Award nor the Units subject to this Award may be sold,
assigned, transferred, exchanged or encumbered other than by will or the laws of descent and distribution. Any attempted transfer in
violation of this Section&nbsp;2 shall be of no effect and shall result in the forfeiture of all Units. The Units and your right to receive
Shares in settlement of the Units under this Agreement shall be subject to forfeiture as provided in Section&nbsp;4 until satisfaction
of the vesting conditions set forth in Section&nbsp;3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>3.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Vesting
of Units</U></FONT></B><FONT STYLE="font-size: 10pt">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>(a)</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Scheduled
Vesting</U>. If you remain a Service Provider continuously from the Grant Date specified on the cover page&nbsp;of this Agreement (subject
to Section&nbsp;3(b)), then the Units will vest in the numbers and on the dates specified in the Vesting Schedule on the cover page&nbsp;of
this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>(b)</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>&#8239;<FONT STYLE="font-size: 10pt">Accelerated
Vesting</FONT></U><FONT STYLE="font-size: 10pt">. Notwithstanding Section&nbsp;3(a):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(1)</I></FONT><I>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Death
or Disability</FONT></I><FONT STYLE="font-size: 10pt">. If your Service terminates prior to the final scheduled vesting date due to your
death or Disability, all of the unvested Units shall vest as of such termination date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(2)</I></FONT><I>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Change
in Control</FONT></I><FONT STYLE="font-size: 10pt">. If and to the extent this Award is continued, assumed or replaced in connection with
a Change in Control, and if within one year after the Change in Control you experience an involuntary termination of Service for reasons
other than Cause, or you terminate your Service for Good Reason (as defined below), then all of the unvested Units shall vest as of such
termination date. In addition, vesting of the Units may be accelerated during the term of the Award under the circumstances described
in Sections 12(b)&nbsp;and 12(c)&nbsp;of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(3)</I></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Definition
of &ldquo;Good Reason</I>.&rdquo; &ldquo;Good Reason&rdquo; shall, if you have an employment agreement with the Company, have the meaning
set forth in your employment agreement. If you do not have an employment agreement with the Company, &ldquo;Good Reason&rdquo; means
the existence of one or more of the following conditions without your written consent, so long as you provided written notice to the
Company of the existence of the condition not later than 90 days after the initial existence of the condition, the condition has not
been remedied by the Company within 30 days after its receipt of such notice and your Service terminates no later than 130 days after
the condition&rsquo;s initial occurrence: (i)&nbsp;any material, adverse change in your duties, responsibilities, or authority; (ii)&nbsp;a
material reduction in your base salary or bonus opportunity that is not part of a general reduction applicable to employees in the same
classification or grade as you; or (iii)&nbsp;a geographical relocation of your principal office location by more than 50 miles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>4.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Effect
of Termination of Service</U></FONT></B><FONT STYLE="font-size: 10pt">. Except as otherwise provided in accordance with Section&nbsp;3(b),
if you cease to be a Service Provider, you will forfeit all unvested Units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>5.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Settlement
of Units</U></FONT></B><FONT STYLE="font-size: 10pt">. After any Units vest pursuant to Section&nbsp;3, the Company shall, as soon as
practicable (but no later than March&nbsp;15 of the year following the calendar year in which such Units vest), cause to be issued and
delivered to you, or to your designated beneficiary or estate in the event of your death, one Share in payment and settlement of each
vested Unit. Delivery of the Shares shall be effected by the issuance of a stock certificate to you, by an appropriate entry in the stock
register maintained by the Company&rsquo;s transfer agent with a notice of issuance provided to you, or by the electronic delivery of
the Shares to a brokerage account you designate, and shall be subject to the tax withholding provisions of Section&nbsp;6 and compliance
with all applicable legal requirements as provided in Section&nbsp;16(c)&nbsp;of the Plan, and shall be in complete satisfaction and
settlement of such vested Units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>6.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Tax
Consequences and Withholding</U></FONT></B><FONT STYLE="font-size: 10pt">. No Shares will be delivered to you in settlement of vested
Units unless you have made arrangements acceptable to the Company for payment of any federal, state, local or foreign withholding taxes
that may be due as a result of the delivery of the Shares. You hereby authorize the Company (or any Affiliate) to withhold from payroll
or other amounts payable to you any sums required to satisfy such withholding tax obligations, and otherwise agree to satisfy such obligations
in accordance with the provisions of Section&nbsp;14 of the Plan. If you wish to satisfy some or all of such withholding tax obligations
by delivering Shares you already own or by having the Company retain a number of Shares upon settlement of the Units, you must make such
a request which shall be subject to approval by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>7.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Shareholder Rights</U></FONT></B><FONT STYLE="font-size: 10pt">. The Units subject to this Award do not entitle you to any rights of
a shareholder of the Company&rsquo;s common stock. You will not have any of the rights of a shareholder of the Company in connection
with the grant of Units subject to this Agreement unless and until Shares are issued to you upon settlement of the Units as provided
in Section&nbsp;5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>8.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Governing
Plan Document</U></FONT></B><FONT STYLE="font-size: 10pt">. This Agreement and the Award are subject to all the provisions of the Plan,
and to all interpretations, rules&nbsp;and regulations which may, from time to time, be adopted and promulgated by the Committee pursuant
to the Plan. If there is any conflict between the provisions of this Agreement and the Plan, the provisions of the Plan will govern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>9.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Choice
of Law</U></FONT></B><FONT STYLE="font-size: 10pt">. This Agreement will be interpreted and enforced under the laws of the state of Delaware
(without regard to its conflicts or choice of law principles).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>10.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Binding
Effect</U></FONT></B><FONT STYLE="font-size: 10pt">. This Agreement will be binding in all respects on your heirs, representatives, successors
and assigns, and on the successors and assigns of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>11.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Section&nbsp;409A
of the Code</U></FONT></B><FONT STYLE="font-size: 10pt">. The award of Units as provided in this Agreement and any issuance of Shares
or payment pursuant to this Agreement are intended to be exempt from Section&nbsp;409A of the Code under the short-term deferral exception
specified in Treas. Reg. &sect; 1.409A-l(b)(4).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>12.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Compensation
Recovery Policy</U></FONT></B><FONT STYLE="font-size: 10pt">. All compensation paid or payable pursuant to this Agreement shall be subject
to potential forfeiture or recovery by the Company in accordance with any compensation recovery policy adopted by the Board or any committee
thereof, including but not limited to in response to the requirements of Section&nbsp;10D of the Exchange Act and any implementing rules&nbsp;and
regulations thereunder adopted by the Securities and Exchange Commission or any national securities exchange on which the Company&rsquo;s
common stock is then listed. This Agreement will be automatically amended to comply with any such compensation recovery policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>13.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Other
Agreements</U>. </FONT></B><FONT STYLE="font-size: 10pt">You agree that in connection with the settlement of vested Units, you will execute
such documents as may be necessary to become a party to any stockholder, voting or similar agreements as the Company may require.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>14.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Restrictive
Legends</U>. </FONT></B><FONT STYLE="font-size: 10pt">The Company may place a legend or legends on any certificate representing Shares
issued in settlement of vested Units summarizing transfer and other restrictions to which the Shares may be subject under applicable
securities laws, other provisions of this Agreement, or other agreements contemplated by Section&nbsp;13 of this Agreement. You agree
that in order to ensure compliance with the restrictions referred to in this Agreement, the Company may issue appropriate &ldquo;stop
transfer&rdquo; instructions to its transfer agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>15.</U></B></FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Electronic
Delivery and Acceptance</U></FONT></B><FONT STYLE="font-size: 10pt">. The Company may deliver any documents related to this Restricted
Stock Unit Award by electronic means and request your acceptance of this Agreement by electronic means. You hereby consent to receive
all applicable documentation by electronic delivery and to participate in the Plan through an on-line (and/or voice activated) system
established and maintained by the Company or the Company&rsquo;s third-party stock plan administrator.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>By signing the cover page&nbsp;of this Agreement
or otherwise accepting this Agreement in a manner approved by the Company, you agree to all the terms and conditions described above and
in the Plan document.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>tm2514641d1_10-4.htm
<DESCRIPTION>EXHIBIT 10.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.4</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2025 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Performance Stock Unit Agreement</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Tactile Systems Technology,&nbsp;Inc. (the &ldquo;<I>Company</I>&rdquo;),
pursuant to its 2025 Equity Incentive Plan (the &ldquo;<I>Plan</I>&rdquo;), hereby grants an award of Performance Stock Units to you,
the Participant named below. The terms and conditions of this Award are set forth in this Performance Stock Unit Agreement (the &ldquo;<I>Agreement</I>&rdquo;),
consisting of this cover page, the Terms and Conditions on the following pages&nbsp;and the attached <U>Exhibit&nbsp;A</U>, and in the
Plan document, a copy of which has been provided to you. Any capitalized term that is used but not defined in this Agreement shall have
the meaning assigned to it in the Plan as it currently exists or as it is amended in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding: 2pt 5.4pt; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of Participant:</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; padding: 2pt 5.4pt; width: 67%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; padding: 2pt 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Target
    Number of Performance Stock Units:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; padding: 2pt 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; padding: 2pt 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Grant
    Date:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; padding: 2pt 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; padding: 2pt 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Performance
    Period:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; padding: 2pt 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; padding: 2pt 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Performance
    Years:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; padding: 2pt 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; padding: 2pt 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vesting
    Schedule:</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; padding: 2pt 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of Units determined in accordance with <U>Exhibit&nbsp;A</U> to have been earned during [the Performance Period] [each Performance
    Year] will vest on the dates specified in Section&nbsp;4(a)&nbsp;of the Award Terms and Conditions.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 2pt 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Performance
    Goals:</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding: 2pt 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    <U>Exhibit&nbsp;A</U></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">By
signing </FONT>below or otherwise evidencing your acceptance of this Agreement in a manner approved by the Company, you agree to all of
the terms and conditions contained in this Agreement and in the Plan document and acknowledge that you have received and reviewed these
documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Tactile
Systems Technology,&nbsp;Inc.</B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2025 Equity Incentive Plan</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Performance Stock Unit Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Terms and Conditions</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Award
of Performance Stock Units</U>.</B> The Company hereby confirms the grant to you, as of the Grant Date and subject to the terms and conditions
of this Agreement and the Plan, of an award of Performance Stock Units (the &ldquo;<I>Units</I>&rdquo;) with the Target Number of Performance
Stock Units (the &ldquo;<I>Target Number of Units</I>&rdquo;) specified on the cover page&nbsp;of this Agreement. For each Performance
Year, one-third of the Target Number of Units will be subject to the applicable Performance Year&rsquo;s payout factors specified in <U>Exhibit&nbsp;A</U>
(the &ldquo;<I>Performance Year Target Number of Units</I>&rdquo;). The number of Units that may actually be earned and become eligible
to vest pursuant to this Award can be between [ ]% and [ ]% of the Target Number of Units. Each Unit that is earned as a result of the
performance goals specified in <U>Exhibit&nbsp;A</U> to this Agreement having been satisfied and which thereafter vests represents the
right to receive one Share of the Company&rsquo;s common stock. Prior to their settlement or forfeiture in accordance with the terms of
this Agreement, the Units granted to you will be credited to a performance stock unit account in your name maintained by the Company.
This account will be unfunded and maintained for book-keeping purposes only, with the Units simply representing an unfunded and unsecured
contingent obligation of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Restrictions
Applicable to Units</U>. </B>Neither this Award nor the Units subject to this Award may be sold, assigned, transferred, exchanged or encumbered
other than by will or the law of descent and distribution. Any attempted transfer in violation of this Section&nbsp;2 shall be void and
without effect. The Units and your right to receive Shares in settlement of any Units under this Agreement shall be subject to forfeiture
except to extent the Units have been earned and thereafter vest as provided in Sections 4 and 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>No
Shareholder Rights</U></B>. The Units subject to this Award do not entitle you to any rights of a holder of the Company&rsquo;s common
stock. You will not have any of the rights of a shareholder of the Company in connection with any Units granted or earned pursuant to
this Agreement unless and until Shares are issued to you in settlement of earned and vested Units as provided in Section&nbsp;5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Vesting
and Forfeiture of Units</U>.</B> The Units shall vest at the earliest of the following times and to the degree specified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Determination
of Units Earned; Scheduled Vesting</U>. Subject to Sections 4(b)-(d), and subject to any separate employment (or similar) agreement or
severance plan to which you are a party or a participant, the number of Units that have been earned during each Performance Year, as determined
by the Committee in accordance with <U>Exhibit&nbsp;A</U> (the &ldquo;<I>Earned Units</I>&rdquo;), will vest as follows, so long as your
Service has been continuous from the Grant Date to each applicable vesting date (each, a &ldquo;<I>Vesting Date</I>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i)&nbsp; Earned Units with respect to
the [___] Performance Year and Earned Units with respect to the [___] Performance Year shall vest on the date the Committee certifies
(A)&nbsp;the degree to which the performance goals for the [___] Performance Year have been satisfied, and (B)&nbsp;the number of Units
that have been earned during the [___] Performance Year as determined in accordance with <U>Exhibit&nbsp;A</U>, which certification shall
occur no later than March&nbsp;15 of the calendar year immediately following the [___] Performance Year; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii)&nbsp; Earned Units with respect
to the [___] Performance Year shall vest on the date the Committee certifies (A)&nbsp;the degree to which the performance goals for the
[___] Performance Year have been satisfied, and (B)&nbsp;the number of Units that have been earned during the [___] Performance Year as
determined in accordance with <U>Exhibit&nbsp;A</U>, which certification shall occur no later than March&nbsp;15 of the calendar year
immediately following the [___] Performance Year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt">page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the avoidance of doubt, the Committee shall certify (1)&nbsp;the
degree to which the performance goals for the [___] Performance Year have been satisfied, and (2)&nbsp;the number of Units that have been
earned during the [___] Performance Year as determined in accordance with <U>Exhibit&nbsp;A</U>, which certification shall occur no later
than March&nbsp;15 of the calendar year immediately following the [___] Performance Year, but any Earned Units with respect to the [___]
Performance Year shall vest in accordance with Section&nbsp;4(a)(i)&nbsp;above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Disability</U>.
If your Service terminates by reason of your Disability prior to an applicable Vesting Date, then you will be entitled to have vest on
the date your Service terminates all unvested Earned Units for completed Performance Years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Death</U>.
If your Service terminates by reason of your death prior to an applicable Vesting Date, then you will be entitled to have vest on the
date your Service terminates (i)&nbsp;for completed Performance Years, all unvested Earned Units; and (ii)&nbsp;for uncompleted Performance
Years, a pro rata portion of the applicable Performance Year Target Number of Units. The pro rata portion shall be determined by multiplying
the Performance Year Target Number of Units by a fraction whose numerator is the number of days during the Performance Year prior to your
Service termination date and whose denominator is the number of days in the Performance Year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Change
in Control</U>. If and to the extent this Award is continued, assumed or replaced in connection with a Change in Control, and if within
one year after the Change in Control you experience an involuntary termination of Service for reasons other than Cause, or you terminate
your Service for Good Reason (as defined below), then as of such termination date a number of Units equal to following shall vest: (i)&nbsp;for
any Performance Year that has ended, the Earned Units, plus (ii)&nbsp;for any other Performance Year, the Performance Year Target Number
of Units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If this Award is not continued, assumed or replaced
in connection with a Change in Control and vesting of the Units is being accelerated in accordance with Sections 12(b)&nbsp;and 12(c)&nbsp;of
the Plan, then in such case the number of Units that may be vested shall be (i)&nbsp;for any Performance Year that has ended, the Earned
Units, plus (ii)&nbsp;for any other Performance Year, the Performance Year Target Number of Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<I>Good Reason</I>&rdquo; shall, if you
have an employment agreement with the Company or are subject to a Company severance policy, have the meaning set forth in your employment
agreement or such severance policy. In all other cases, &ldquo;<I>Good Reason</I>&rdquo; means the existence of one or more of the following
conditions without your written consent, so long as you provided written notice to the Company of the existence of the condition not later
than 90 days after the initial existence of the condition, the condition has not been remedied by the Company within 30 days after its
receipt of such notice and your Service terminates no later than 130 days after the condition&rsquo;s initial occurrence: (i)&nbsp;any
material, adverse change in your duties, responsibilities, or authority; (ii)&nbsp;a material reduction in your base salary or bonus opportunity
that is not part of a general reduction applicable to employees in the same classification or grade as you; or (iii)&nbsp;a geographical
relocation of your principal office location by more than 50&nbsp;miles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Forfeiture
of Unvested Units</U>. If your Service terminates prior to the applicable Vesting Date under circumstances other than as set forth in
Sections 4(b)&nbsp;through (d), or as set forth in any separate employment (or similar) agreement or severance plan to which you are a
party or a participant, all unvested Units shall be forfeited immediately after the termination of your Service. To the extent you are
a participant in the Company&rsquo;s Executive Employee Severance Plan and these Units are subject to pro rata vesting pursuant to the
terms of that plan, any references to &ldquo;the vesting or performance period&rdquo; therein as applied to these Units shall be the period
of time between the Grant Date of these Units and the third anniversary of the Grant Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt">page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Settlement
of Units</U></B><I>. </I> Subject to Section&nbsp;7 below, as soon as practicable after any date on which Units vest (but no later than
the 15<SUP>th</SUP> day of the third calendar month following the applicable vesting date), the Company shall cause to be issued and delivered
to you (or to your personal representative or your designated beneficiary or estate in the event of your death, as applicable) one Share
in payment and settlement of each vested Unit. Delivery of the Shares shall be effected by the issuance of a stock certificate to you,
by an appropriate entry in the stock register maintained by the Company&rsquo;s transfer agent with a notice of issuance provided to you,
or by the electronic delivery of the Shares to a brokerage account you designate, and shall be subject to the tax withholding provisions
of Section&nbsp;6 and compliance with all applicable legal requirements as provided in Section&nbsp;17(c)&nbsp;of the Plan, and shall
be in complete satisfaction and settlement of such vested Units. If the number of Units that vest on a Vesting Date include a fractional
Unit, the Company shall round the number of vested Units to the nearest whole Unit prior to issuance of Shares as provided herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Tax
Consequences and Withholding</U></B>. No Shares will be delivered to you in settlement of vested Units unless you have made arrangements
acceptable to the Company for payment of any federal, state, local or foreign withholding taxes that may be due as a result of the delivery
of the Shares. You hereby authorize the Company (or any Affiliate) to withhold from payroll or other amounts payable to you any sums required
to satisfy such withholding tax obligations, and otherwise agree to satisfy such obligations in accordance with the provisions of Section&nbsp;14
of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Compensation
Recovery Policy</U></B>. All compensation paid or payable pursuant to this Agreement shall be subject to potential forfeiture or recovery
by the Company in accordance with any compensation recovery policy adopted by the Board or any committee thereof, including but not limited
to in response to the requirements of Section&nbsp;10D of the Exchange Act and any implementing rules&nbsp;and regulations thereunder
adopted by the Securities and Exchange Commission or any national securities exchange on which the Company&rsquo;s common stock is then
listed. This Agreement will be automatically amended to comply with any such compensation recovery policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><U>Additional
Provisions</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT><B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B><FONT STYLE="font-size: 10pt"><U>Governing
Plan Document</U>. This Agreement and the Award are subject to all the provisions of the Plan, and to all interpretations, rules&nbsp;and
regulations which may, from time to time, be adopted and promulgated by the Committee pursuant to the Plan. If there is any conflict between
the provisions of this Agreement and the Plan, the provisions of the Plan will govern. If there is any conflict between this Agreement
or the Plan and any separate employment (or similar) agreement or severance plan to which you are a party or a participant, the provisions
of the other agreement or plan will govern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Choice
of Law</U>.&nbsp;&nbsp;This Agreement shall be interpreted and enforced under the laws of the State of Delaware (without regard to its
conflicts or choice of law principles).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Binding
Effect</U>. This Agreement will be binding in all respects on your heirs, representatives, successors and assigns, and on the successors
and assigns of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Section&nbsp;409A
of the Code</U>. The award of Units as provided in this Agreement and any issuance of Shares or payment pursuant to this Agreement are
intended to be exempt from Section&nbsp;409A of the Code under the short-term deferral exception specified in Treas. Reg. &sect; 1.409A-l(b)(4).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Electronic
Delivery and Acceptance</U>. The Company may deliver any documents related to this Award by electronic means and request your acceptance
of this Agreement by electronic means. You hereby consent to receive all applicable documentation by electronic delivery and to participate
in the Plan through an on-line (and/or voice activated) system established and maintained by the Company or the Company&rsquo;s third-party
stock plan administrator.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>By signing the cover page&nbsp;of this Agreement or otherwise
accepting this Agreement in a manner approved by the Company, you agree to all the terms and conditions described above and in the Plan
document.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt">page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-variant: small-caps"><B>Exhibit&nbsp;A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Tactile
Systems Technology,&nbsp;Inc.</B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Performance Stock Unit Agreement</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Performance Goals and Determination of Earned
Units</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt">page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>tcmd-20250507.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaOJGbOdzZR+SYkxtmBxbSlqHyItpbPq8CHxARamQdkO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:TCMD="http://tactilemedical.com/20250507" elementFormDefault="qualified" targetNamespace="http://tactilemedical.com/20250507">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://tactilemedical.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="tcmd-20250507_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="tcmd-20250507_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>tcmd-20250507_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>tcmd-20250507_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://tactilemedical.com/role/Cover" xlink:href="tcmd-20250507.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://tactilemedical.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 07, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  07,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TACTILE SYSTEMS TECHNOLOGY INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001027838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">41-1801204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3701
Wayzata Blvd<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Minneapolis<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">55416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">355-5100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, Par Value $0.001 Per Share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TCMD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( !J'J5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( !J'J5I$XLH6[@   "L"   1
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
MT%116F]?(+3E'S/X%<M4C66C 1-702:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8
M('_.;Z?D3EJ(X53"Q,!J9S]6:\?1TDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\
M]L3MGXS*VG0T;1K@X_%X.+;+THMP' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1
MIJJ-4T_3]WW?ZYMHG J-6T_3:W?=TXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]
MKFNDZ19H0D;CZWH2%;7E0-,@ %AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1
M_L;%!-9ITAF6-$9RG9 %#@ WQ-%,4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'
M@B'%W*_]]9>[R:0S>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ
M^R-;88<G;CL3<CH<9T)\S_;VD:4E,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV
M6'WV3T=N(]>IP+,BUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0' *D"3&6H8;X
MM,:L$> 3?;>^",C?C8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<
MHY=8%0&7&-\TJC4LQ=9XE<#QK9P\'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^
MG-- \)0O)/I*D8]ILR.G=";-Z#,:P4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS
M1B&$:;OP'J\DCIJMPA$K0CYB&38:<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^
M8,CLS9%USM:1#A&27C="/F+.BY 1OQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^
MAM4S;"R.]T?4%TKD#R:G/^DR- >CFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX
M"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$
M^ZXQVM<T+BAC5W+-R,=4KY,IV#F?P.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$D
MN/R+RO JQ GH9%LE"<M4TV4WBA*>0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/
M^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KTL<QP3A[+##MG/)(=MG>@'37[]EUVY".E
M,%.70[@:0KX#;;J=W#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OG
MP5&PH^\\EAW'B/*B(>ZAAIC/PT.'>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@
M9& MH >#KU$"\E)58#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB
M4CG":9@39ZO*WF6QP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB
M\QE3ON<K2<15.+]%,[82EQB\X^;'<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)
M+%N(61+B35WMU>>;G*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(
M3)QYQ1$!=$4"(Y4<!A87,N10[I*0!A,!S93)1/ "@F2F'("8^@N]\@RY*17.
MK3XY?T4L@X9.7M(E$A2*L P%(1=RX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS
M<D/85"7SKMHF"X7;XE3-NQJ^)F!+PWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;
M>KC"1:S_6-8>^3+?.7#;.MX#7N83+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!
M()O\UMND]MW@#'S4JUJE9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8
M\PRA9CC?AT6:&C/5BZPYC0IO0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^
M[PVPPL2.X>V+OP%02P,$%     @ &H>I6I="OHAO!   *Q$  !@   !X;"]W
M;W)K<VAE971S+W-H965T,2YX;6R-F%USXC84AN_W5VC<3J>=2>(//I,",X20
M768#H3'=S+;3"V$+T,267%D.H;^^1X;8-#7'< &6[?/Z\='Q>V1Z6ZE>T@UC
MFKS%D4C[UD;KY,:VTV##8II>R80).+*2*J8:AFIMIXEB-,R#XLCV'*=MQY0+
M:]#+]\W5H"<S'7'!YHJD61Q3M;MED=SV+==ZW_'$UQMM=MB#7D+7S&?Z]V2N
M8&07*B&/F4BY%$2Q5=\:NC>W7LL$Y&=\XVR;'FT3<RM+*5_,8!+V+<<0L8@%
MVDA0^'EE(Q9%1@DX_CZ(6L4U3>#Q]KOZ?7[S<#-+FK*1C)YYJ#=]JVN1D*UH
M%NDGN?W"#C>4 P8R2O-OLMV?VVQ:),A2+>-#,!#$7.Q_Z=LA$<<!K1,!WB'
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MVCT'= 33JFA$)B)D;^0KVU6AXDH.Y,_Q.MU&%\&Z+K"NS\%:T#<R"8&-KWA
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M              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @
M&H>I6D3BRA;N    *P(  !$              ( !PP   &1O8U!R;W!S+V-O
M<F4N>&UL4$L! A0#%     @ &H>I6IE<G",0!@  G"<  !,
M ( !X $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  :AZE:ET*^
MB&\$   K$0  &               @($A"   >&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L! A0#%     @ &H>I6I^@&_"Q @  X@P   T
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;72YX;6Q02P4&      D "0 ^ @  &A0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2514641d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tactilemedical.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>tcmd-20250507.xsd</File>
    <File>tcmd-20250507_lab.xml</File>
    <File>tcmd-20250507_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2514641d1_8k.htm">tm2514641d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2514641d1_8k.htm": {
   "nsprefix": "TCMD",
   "nsuri": "http://tactilemedical.com/20250507",
   "dts": {
    "schema": {
     "local": [
      "tcmd-20250507.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "tcmd-20250507_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tcmd-20250507_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2514641d1_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://tactilemedical.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-05-07",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2514641d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-05-07",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2514641d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://tactilemedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001104659-25-046813-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-046813-xbrl.zip
M4$L#!!0    ( !J'J5K)B"1", ,  /0+   1    =&-M9"TR,#(U,#4P-RYX
M<V2U5MMRVC 0?>],_T'U:\878,B%0#(IF21T2$DA2=.\=&1;$ VVY$AR</KU
ME6S+7 PNT)8G>?><L[O>79GV>1(&X TQCBGI&#7+,0 B'O4QF72,AY%Y,>KV
M>@8X/_OX <A?^Y-I@BN, K\%+JEG]LB8GH*O,$0M<(T(8E!0=@H>81 K"[W"
M 6*@2\,H0 ))1Q:I!0XMQP6FN87L(R(^90_#7B'[(D3$6[8]F\TL0M_@C+(I
MMSP:;B<X$E#$O%!S$B?_;4>_Q=PKR ?PHCD[2H;X:8+(<=R'C6?O.QQ\N78'
M_J_GX<'HQS01X>?$'06O-^\]$;EWK\?=F^1B",-O_G20A6QS[P6%$,A>$-XQ
M5'UY>;.&1=G$KCM.S7ZZ[8]2G)$!6TF R70=O'9R<F*G7@TM(1.7!5JZ82NW
M"SDJE*475^ QX0(2;PGOBX*P"&[:F7,)BM="#S,HUE ?K> X\JP)?;.E0^+K
M#0V,N3F!,"K 8\C=5#1W+($Y$V6@-*Z"3/$>(;X6FKF6"/?=V\L"*Z GY."'
MR,<>#-1D*FS3:3I'<KV4@X@KRL)+-(9Q(--YC6& QQCY!A"039!0H\8CZ*&M
M-/740D*H'&ZY8+E%V:((R^DM#-*DNMUB-$#WL@R@#G*[J@(IB-VE\IHP /8[
M1G9<D-2B/AIC@M,$\IVJ 5-M4*Q*EL>4V;97P66EF"-_0,[2<\00E_2TL+XT
MY/P<4LV5)7AQL!=UGE\5,[?KUUEZSWJUAF@,TI5LJ>'I&!RK.]'(;2\,C3N&
M\$+?U%W]*<NVY'!IB(I0L9)ICU;?5!Y82T#FE51*5X84H1%B LL)7[@7LM2Q
M4/2[A3! Q>$&L/]AY0%T=ZU<4E#P'TON*_URK6U[>;_D\^H.MF6YE E 2BM=
M=:]F7X0^]5*I"HIZ,C7/5":S5C<;-2OA_CS379*8OX'=DM"\/9+8<+NOB\\W
MP=5!C5!CVZ ;OA*50==R;!0(KBU[I[#X3?F+'%*9G9)8:J<OF*TDE&C=E'UL
MU#:G\R=F^LSW&@*/QD2P]UT&89&B'_;KQOS?P':-T/BL">H/PKYA]YB"<O!U
M(]"V,S5Y_ U02P,$%     @ &H>I6B0NS8S\"@  ?X8  !4   !T8VUD+3(P
M,C4P-3 W7VQA8BYX;6S-G5UOXS86AN\7V/_ >F]V@7&<.$"!I#,M,IZD,)HF
M:>R9[FZQ*&B)<8309$#)B?WOEY1$6:)X)"6+)3D7,Q[Q/=1+\3%)?1U__&FW
MH>B%B#3A[-/HY.AXA B+>)RP]:?1U\7X8C&;ST<HS3"+,>6,?!HQ/OKIQ[_^
M!<D_'[\;C]%50FA\CK[P:#QG#_P'=(,WY!S]3!@1../B!_0-TZW:PJ\22@2:
M\<TS)1F1!<6.S]'W1\<K-!X/J/8;83$77^_G5;6/6?:<GD\FKZ^O1XR_X%<N
MGM*CB&^&5;C(<+9-J]J.=\?EGR+\(TW8T[GZ:X53@N3A8NGY+DT^C=1^R]V^
MGAYQL9Y,CX]/)O_\]7H1/9(-'B=,';:(C'24JL46=W)V=C;)2[6TI=RM!-7[
M.)UH.U7-LC3IT-><I,EYFMN[YA'.\E[OW0T"%>I_8RT;JTWCD^GX].1HE\8C
M??#S(R@X)??D >7-/,_VSY*D-%$@C,IMCX(\V,U0(28J?L+(&F<D5CLZ4SLZ
M^5[MZ&_EYFN\(G2$E%+R ;;KK%%7&31Q;?:.B(3'E^Q]KLUH3_;E=T=D_T,#
MZO'.F[#D&:;O,E^/=&[[AKSOB!_BW!]I.<R3]QWI6N3_Q7;6MOSFPVL_KE1M
MO):?&A;)+I,3&(FU255%QPB<[R&?&,JZJ]IYU*B7JM&<BW;;U<R8UYF2Z&C-
M7R8Q263=TU/U8:P^Y,V6__ESQN5"X&*59@)'F:XI;\:GD:5\8EI2R@NA?6$1
M]32N5$PB+J>FYVQ,B\-8A#\(OK'NMFPUMQ3^25=5?'%8Y"X HPV9("G?BHB\
MJ5?J;J&C5#K:4*E0*RK"QE\7HQ]S#?I#J_[S<7*HQ4%'RR70=D-8MI0U6EK0
M+';5S393NI?K94%TLL60V<=:@I3&<0=?R!W':N=7%*\M]HUR5UULM:7[N%$8
M1"?;')F]7&F0$OGJYB\DC43RK);S7>UHR)QWNL5DJ^]KFK 0:!N#2:AI/0WL
M]V2=J*E%65#GMT1M[!C& +WKH;_3MCD76,5!0#/$(3A;U(-0%>6)HPO&MIC>
MDV<NNO!IREQ38S-IPE+7!,6(Q1B(1J%%A=@3$;]MY1D[$73?"T5+Z9H+P*J)
MAB$+B@Z[-Q"02NZ7D:7 +$W4 -8+25OJ_'0#,-LZ]3!T07$"F(-/22J]7U(6
MCX12=3L L_X!Q29V30MLV.2EK0R*&- >R$P>@<J0<+"Y?%&K<[E,&MC8FMXG
M/"W;7?Q4XF 1,AT.I"@/0RK.$TFUVQ ]#+64KND!K)K<&+*@B+%[ UDIY"C7
M^X?DDL6#$*ET?@ Q;-KQ*$4!PM%TUH>&5/L$XRI)(TP++U=R6]K1/(O6-2"@
M71.2EC H4"!W("Q%@&8F#_$*S+\(%L-PJ2G]P-*R:D>ED@4(BNFM#Q.E]P+)
M;"M$PS4\X\!29S=E>\Q6]V<!71"@])AKW;4MY U0/,U ERQ+LKUZG.YFNUD1
M86E<6^**#<B<9L(L#X(%P)3)0"%#2H<*H9>>UW<)6*8>8@2;8\K<$F WV:2@
MJ0F(!*LQ@(:#-G^FU L1,SDR"4SG+":[7\@>;%=+YY8)P&83"D,4$!5V9P 6
MI1CE:B3E7L"X$\D&B_TBB7JFBK;0+1J0T28;IBH@. !K !VE&BWF,Y\SR1+O
MYK$$-7E(BN?!>R@!]6YAZ;'=9 80!X1.MT. (!F$FE$^09JSB(MG7GO<8<:W
M<@#<SW@,KU!ZHMQ"-:@)3;0Z0P(";(A/ +-&Z(?BF13$U6L\>05(U>"%N(LX
ME@<J+?^Y3A@Y =MOU;JEJ\-NDRF+,""28'< /Z7R@_Z 5 RZ9:% ,WU#4Z?^
MH9D.A68:-#33]T"S?.6!0'/ZAJ:>^H?F="@TIT%#<_HN:&3'>QUK9O+CK5CR
M5]O#V:#2"S)MJU9@#K+P<&EYZX-%!:CUC KQB4F^L+H5=X*_)"R"E\R0W LP
M@&DK-88V/'3L!OOXJ1;$.L[K6%,LRGN_)%KF9Y1IFK0/,84F/$B:QGH'ET+M
M$XD[GF:8_CMY[CP1MXN]X&$U;(6DH0P/%9N]/F"*&"2#?)Q8E[BJ&QK65\F,
M<G>O %ML'5X!KA4& 8'-4?L5X.+J22%RW<V*44$P,"(TBYUULL54U<>ULC"Z
MN&VHU</Y]UIJ?'R15787>O?(&?R 0%OBJJ<A<[JWS?(@>APP9?9Z+D.YSM/5
M>)5A(K4/W[4R9S.[::>:R'5!$+UKNFE-T[K<<6_^+I),[GG&-YLM*^_RV)X;
M!'2N>KG3INYQJRB(WN]R9I)0:E%3[!B+!:=)E&0)6_\J3SY%@FVMLHE< 0$;
MU#2T%4&@ -HR.3@(D58ZAN!.$ 4AD1V1OP2H$@N)VX<'ZVS?)78%1;]A#0>L
M# *27GLF+#)@'-4B4!&"\AB_V,S3=$O$F^"QA'A""#0/@-32AX@39+(7JB+0
M)UL+$FWE_+@_F:Z6249M)Y=MB;,Y"3!7S4A&>1!L *9,%O(RQ!_0R?3OJW\@
M'>6X^V_X4F"5.W:QWZPX!;)/656N(.BPJ#FP2()  ?9ETG##42E%A=9'=JJ&
M64MSC')7 %AMZ:YO% ;1Z39'K2]_HZ\]#?F7N^A1FB+ "PEVF>NAWV;2'/[K
MFB 0Z##6.BDII4AK?;R0<)BRUOV+@+6W1<"Z9Q&P#G$1L!ZZ"%A[6P3HW18I
M0N2X=+NBR1H#R0D[U:ZAZ+!L\F&1!H4*[ \<,ZH0=(AQG=$R3W&FTO.+3;[_
M*_G!TDI YRRG99?-*JFE310$(UW.6FDMBZ1S-3%2:M=<;.,D(W%AYBIAF$4)
MIE5Z1-L5\?X09[0,-%^!TZ,/@Z%A)ELX%6$ZEV$5>$AUZ?I2>O$ QN^$TE\8
M?V4+@E/.2%Q<2['=*>K6NWUBIL=V\Z$90!P$3D,< H_.J*#QDXI".JR\$N:%
MI&^<;EF&1?XNN;"-3(#.+3F S28QAB@@4NS. $(J,2K4?E[0+K)'5(NLXG>'
MP 9"<L>O:W>:-M[:MFH#8J;3(/0.=YGSX[ V+J(\O6*9$?5[$<D+^8(S7'H#
MVPO)7;]4V67:?)O2I@T(H4Z#X/N358Q*%8,U4]Y2QHB97&JM><=3XH;*?>*8
MEL5V[IA*$A >-E\=&60$TEHO+"PVF-+/VS1A)(4G(D/EE@6KQ28+#4E +-A\
M 2SD4J2U7EBXW!"QEM/;SX*_9H]E?E:P;8#:+1N=EIN,6*4!L=+E#V!&AZ B
M1J?4]0//[I!0O,BR"+?4(G6,#6C68*:E"PD8R%R+%DHB=;WEAF=HR='7E*#L
MD:#+\F?HZIG@BWI\_=)(%*D7(HI5.8NQL"'4)7;^JR.@X=9OC[2408#4:P_^
M'9(J ND0Q]3<2H9%_3PN-S'/R 9\VZ$_Q!5!0\UKCOKT0= TT*3)5![6/+G.
M Y&*])G-J)[<'E[B-42.5\86@\;"N*8(@A'0%K0LKO]6@)_<>=L53:(KRC%\
ME:6A<9PQKVW/2)9W$ 1$0-L5E"(O%Z)<Z:7_/V/V)+;/6;2_$SPB1#UEE5:C
M5=_UMX'1;IEY4Y.:- T*#8BSM_@%"#Q4@6IU?*C-6#XOYJF'QE4V-QX]+1ZQ
M/("WVRQ5,Z@T!E\%[PQR?'MA0 .,FPP=$0&A-\ F=,,ACT1YZ =4!*-:M*?S
ML_20!9#$G_?WY($(]=[!DNRRSW)'3QUG& -B79^]#6Z.>3+7&Q@$A&]U"YWJ
MI:A> 5JI9\3**M ?JA*4UV+[_?+ZIFOY26[6F^1?*YP2N>6_4$L#!!0    (
M !J'J5I8E9<V7 <  .!7   5    =&-M9"TR,#(U,#4P-U]P<F4N>&ULS9Q-
M<]LV$(;OG>E_8-6SK*\FJ1V[&5NQ,IHXMFLY2=M+!B(A"6,0T "@)?W[ J2D
MZ(, UQ>N?;!E:@'L^RP(<@F YQ^6*8^>J=),BHM&YZ3=B*B(9<+$]*+Q==2\
M'/6'PT:D#1$)X5+0BX:0C0]__?I+9'_.?VLVHP&C/#F+/LJX.103^3ZZ)2D]
MBSY1014Q4KV/OA&>N2-RP#A545^F<TX-M5\4#9]%;T_:XZC9!%3[C8I$JJ\/
MPVVU,V/F^JS56BP6)T(^DX543_HDEBFLPI$A)M/;VMK+]OJG*'[.F7@Z<[_&
M1-/(XA+Z;*G91<.UNVYVT3N1:MKJMMN=UC]?;D;QC*:DR83#%M/&II2KI:Q<
MY_3TM)5_NS$]LER.%=^TT6MMW-G6;+]E ?L=3S0[T[E[-S(F)H]Z93.1U\+]
MU]R8-=VA9J?;['5.ECII;.#G!)7D](%.(O?71F_;JB&QL;TBI0F+"7=A:SF3
M5E_:7FG]S0O/%)U<-$R<)K:-[IOVF_8[U\+O>T9F-;>]4S/7N1I1:Z_UN:*:
M"I,+OK$']HK0I;&=BB:;BES[+_//,..*K#M.)VJZ7I:EMD7[L;!<N[-QB,MX
MSP?NHB$/!&]Z=LY<T_AD*I];"666?;?G/C@:O9R$_>='WM#E6!ME?=[4Q,F8
M\KS^'];FP*15@U<;$H^VQG*G]BT.?=H-W:6*(ZD2JBSK35U$Q7L!.^ZD:XO6
MG"A;43.>,;Z-]43)U$=G34)Z'-T%99NHA^:E;3]Q/@PXF9;C/# !\NQ@ "U5
M@T7T(]6Q8G/'I0+LGB60;Q>5;XFVFC%OSIT'.F7.7^>*N_12=S \+GB* ,'W
M,$>*H%JD"%P*D1'^0.=258#?MP3R_@.3=YDV),Q_9T09JO@*0OK(& C[#29L
MCT(DWH^*",T<'PCP8VL@\;>H-QX>C4C(1S/*N<OFB #U\C)[(/9WF-C].E\!
M^.MG=WVWEQ8X^YTB0/Q_OA;\1VJ1(G!/%9.)O:0K /LC8R#U4TSJ'H6HO*]%
M J6]-07G/_BP#^0AH1XP'1->>#2PQW08=XDY%#E*SEDI$Q7[OY0H,/0=8RAR
ME#2T0F+-P/N94GO.!$<5OS44.4H"6B6R9N;7PC"S<H__;[-T_//!Z3[K8RLH
M8Y2DTR<*A>WF28,P;EHCQ/?0$LH8)=<,B4/AW+=Z%.%#D=#E9[H*@3XRA9)&
MR3&#\E!0WRN6$K4:L;AZT#BVA<)&R2S# E%H/Y+E,+&JV(05$X/5T+U%H.Q1
MTDJ07)00#$4LU5SN/"[NR\R>CZN^3()#>D5!:#A0\LT72$<)RF626%QZ_>>&
M"=H)A:+4'#Q'A!> @,Q7@KW[,NQ=.':4/+12YBO!WGL9]AX<.THN6BD3$WO?
M?KQ3CW+AF8'V&D.1H^2B%1(Q@>=7FCMUK^0S*]9'55$_*@%%CYBBAL6B=OCB
M(@_I[1M+*&_$=+5<'";G>ZD-X?^Q>=6=9+D]E#EBXAH26O<#QB+N[J&%;RG1
M@0F4+TJN6BJG;J0NPHH2?_?=MX "14E R\34S/-&NKF/F13!Y[''5E"N*)FD
M3U3= Z];3JR]I_[.U^ 5;"C#ZJ&,FC%^5\Q8#_HR33.Q?D;CF17SF$+QHJ1_
M07DUHQY)SF)FF)A^L7>(BA%>SKG,#@H9)=GS"ZN9\+VB+M+4WG;GZ[C<?@-U
M-YGX1MZ0/90X2JY7+127_%#KC*J7\B\I!8T"2MH'%5WW.$/CS Y[JTYW_.AV
MS'A&F2,K*&N4E,\GJF:VM_)1$;=M;[1*QY+[MX>4&D()HR1X 6DU0][SHQSO
M@0D4+$IF5RH':4RX7L8S(J;4OWJAW!(*&"73"XE#&WNGH+%W^L*Q%R7C\XE"
M8ENL#;=GU-V8LRGQ[R0+%@#OL\$D'I!:]_Z]?,N/V]&MTMR/@?U0CMUC"@6.
MLT4R)*]NU%G"#$T*EP9,$!';E&J[K\V3G5>7@@8 9P\E4#3*X_WOE///0B[$
MB!(M!4V*6_W0$WYO$6@4$.<0*^2BA.";Y)FEI/*%H,IS#GA,H<@1YPX]\G#6
M7A:+FK?7GN+5'2'BOA)0\(B3B&&Q2.O3#'4^LV?ZD1BR]C#$WU<"RA]Q0C$L
M%FW]O.K;"\]4AN?,#PRAM!&7PI9*0X$\2@GG5YEF@NK@V')@"(6,N.:U5!H*
MY.N4JJD=U#XIN3"S]=[.$&Q/ 2ATQ)6M0:DX\)<_]Y$7^]^"Y$NLP6\G0,3N
M%8GUVHTX=@LIBBNY2(CR4 _90[FC;JST"ZV9_)V94;5[_Y0[,[1Y6VC10W4I
M:!10TE6H:)QKZ\Y._N"E=<\.RALQ,2T3AK-G*AMS%@^X),'[\CTS*%_$++1$
M%@K>*R*>5#8W\>I>R9A2-WVBMV<;("$"5@ -"6)^^B(4.(\+9)JZS40R?AK-
MK&A]EYG\1:;6O^!#@V Y:&@P-W$"A"/=!>F?&[UH<K5ZH!.JW#*%1[HT5[:A
MI_!-$: X-#ZH;Q0"8R@)TWGK2->-/>#>55M\XWZY][':(_\#4$L#!!0    (
M !J'J5J=F0,VRD\  ._T 0 4    =&TR-3$T-C0Q9#%?,3 M,2YH=&WM?6N3
MVT:RY7=&\#_@SM[KVQT!R7J/;6D5T7K-:,,C:ZSV3,Q'D "[88$ #8#=XOSZ
MS6=5%AYLRB.YV1(W;JQ'31*H1U96/DZ>?/+7T[_]^'0Z>?+7ER<OX+\1_K\G
MIZ]/?WSY],FW_%_X]%OY^,FSGU[\*WIW^J\?7_[?/RVJLOTANGMGU4:G^3)K
MHC?99?1SM4S*F/\01^^R.E_\"7X(/WVKOULF]5E>_A#=^=/3;\I9LWK\Y-NW
MG:^TV8?V5E+D9_"U.C\[;Q]'YE=/GCU]^>$\G^4MO/WVW2??/GO:?\0.;]EU
M N;E\-4[CR,[O'E6MEE-@SH]>7[Z^L>7T;M_O3M]^;=WT>G+YW]]\].//_WE
M7S$/X?6;Y[=QM'_4@.[=N?<P>OGW7UZ?_BN"=[]\<_KZ'R^CMS^>O!E>L]_Y
M_L^\PK^NFS9?;&!&KWYZ<VH??6N1+/-B\\-5#Z?O-OF_,QX+K<W=V[P&^$S\
M]S?_Y[M[][]__$G_TQ]P,(A?GKY=UZNJR9Y\^\O3VSH4'-76WTTGI^=9M.*?
M1M4B:N&?I\F\S8LL>K=IVFS91*?9_+RLBNILH[)7SF]'+!"_K?-V$\$?0%+R
MBRQZ6R1E=(1/^:9(?UM7C_$/W]3T/X_C*&^BMHJ2MJWA'7%49VV2EU%2IM/)
MLH(')&U&0YAE31LE%TE>)#,829/5%_D<!EI7%WF:U0UL0QW!F/,VK\H&!UYG
MS0K^)YSD D=TF;?G]*3GU7*5E)L8WRL_CY(TI1\F193Q!'*=0#.=P!?AATOX
M_Q(80YW!AVU6IEE*0T<YPL_SFOX.KVT;?9M90WGM-W6#,V^BIJWF[\^K @<?
MXX0C?DV=S38X+IA]-O3#Z:2HRK-;\*)E-%LW>9DU\+#U? [_]=O\-1^^>_MP
M^%YDB[QD8?S8 _@:Q0G.!1Z4F$1@415%=9F79U'J'PLR5A11LEH5FQNZ[_+'
M'(X2/O3.[8=Y^2EEX2@YEH7YXT5 E-W)8@'J!Y28:#S0:ED">P<'.D+] IJ&
MM IL=Q*]6\^:/,V3>A.!,GL+FJ9L.^KCL-/#.SV[_IT^J[-L"=/K[#1NWF6=
MMW!CX*YF139OZZK,YU&BOXBC$JXZN,W@\PJO@"BMYFO\))K#V^!"Q*./#T*M
MW]!E 1^DH@=0!>1SNA;A"LF2^7ET<IG4:716)W AP4VZAG6OZ0&H4VY')V7D
MAHNBUZQGO\*PY 8:?HO((3W@((2#0CB_?B'$?>^J&I8#6" P=$)) (-%[A<P
M)F"#?UK17L,4T3B)3E:K.IN#]H(_1C^CIP0?_0SV39W/0:[X6_KE7^!:@H]!
MA.&Y/Y$4TP>WGB4-RB -[2 YPY*37KOD/*OZDH.B07]'V7B1@RRT5=T<;J2=
MMC2[]BU]GJR;KMUQB<:&ZGA4_=D'..--4VS8M&2?!K^+NB'!KY:WLL4"MAZ=
M.;W(W-45'8&C5*Q3O* 2<ZL<@\/67F;X531DX';+05C:Z80<'2\]K"\VD;.3
M2(.(6DIF35;.R8/"[X"3<]X=D!\(_,P;QS%-H?D!AG?,T@2# P>37C=OP8F"
M9Z9Y<UZ!^P0V&*G%-GD/XYUM6#WZ0=--:%T^6+!UT>(H5^"\D==XAEXK7N\E
MZ,;SI3'<[(/T?@>E3+LPG<#R9V7/27P,X]:!K\LBN5RL"[J+USR%L[H"IV^9
M-_JW@4&C61GC&+.<E'%V098&;/D2EKG.DZ) +_?7=9U7:^?D!B/0(70?/<MP
MN^'=%WP/X/Y$BPS\4O@=#.\HOW"KOG&OBV8UV28#8Y4-)KL#MJ;NV!WX65_R
M5,"&=LM*V.5YCF_EEY\G#1I;\&/XY7Q=P^@'QH/>>UY.)W<?1FFR@=U:P-#<
M$,18(U\=]ZWJ_7X![GN@(Z-7%=^Z$EBA:<T+/*"-V6L<NEF\6761H6T(IX;W
M?9'D!8R9P@[X%Y[\"MX\)&W-.>PQS!17L\$@"4QV0#5$.1P%. =#"P'#;=8D
M3574K, 66.1S&,VZ/:_J_-]L&&0808%C2BN9X.&HBC5]DJY!Q)*T6K5^F>4^
MJ0<?#5^FJ,X9'&TZB?-J#:>CH.!.$+N!4P%::SHAG>!_'@P,SSH_CP]L@Z?A
M\KPJ,M$QM'"T5TY&X4S5&6I$D+!$!! .+?RYH7_TU^AP_PW??XOKO__.D_(,
M="SL]'/X2ET5*O%T.:@0L4J^S!L734SI[C.W&5Q*I=/1+ACSPQ>Q\W<_\;[?
MO;Y]/P&5_?+#G+8].@$%^9:N9U"!\PIGP7'D$JR$.9[UZK($K7[$RIX^1+G
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M\UG?/N\77<AEYE@(Y2=NV9EM,'!\3<TIG"!KE1HC,J1&>J2+;)MK4++/OMM
M0C"6G<W7) _<CZ_'_R^W/T$/U1P*F.O0+JAS)'3"IG[#[PDQK@,F/G5+=VN,
M[7%]MA(M#!O$NR R8>S=D%/CG['&"G;]#0FV$D#">O<-HOVW4*ZI0.E:+Y%7
M.?AR<+!(\EZ (T*Q\0%WT;6/<('M/IR"#/+%2'P[HE['G?-+=T91N/8AJ8Z
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MF8$=*-&G&7);V)VUD2HXQ2M=#R4YG-75>[#"L%".XDE-(NWWP+>#9W&^HZY
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MHJKU&:4S8-/KI*KA B HLW]Z.W"_+)/WF68?W7H*D2H">!I>(\8,81FWR6?
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MK*KH2D,IZ5YCCHXYQ"J:&+B/0UJ<8EYNV<B%I']Z+!YB[CMDF8&MC?%.=YR
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M @NB1#$!@,UOSS+_Z*&4)7-V<!&H^>[AOJ#[XN$^W!<O/9B-FSF\6-=B!)S
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M@$4;_W(G!_%ES0I)O-"EQ&>[9]P.0ATLGG"(T3=E^*$;B)4UL1X"*!DA<LE
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M:PKWA^C'I&F_B@#.GW</X/QQT91OG_WTXE]/\7_\]?1O/S[]_U!+ P04
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MN.":EHBSH<A!@<<=\@!,4LQH>5L(X\,\@R!ZDB%P.(#OK)73B,BGPG'8'CX
MNFO"AT+!!\4(&N!8F4J">23JP9',L;P5;1>6K;#P17_2;A'[T^;L;#!0D<),
M*_]GR@,&W?T-<I"UW7A :<362VG$$Y5&3+D(S^4<?,^NR)O8%?D&Z,79P7OT
MKMNM ##1,09T&DV7(6U7\SQCGH&=].YQC-6C/C<"="9ZY9&M7X%.C81UXGHU
M,OSX5(#.1Q>703"2DQZUYSRH:A.S :2"25/;?[KB_B5V:I<2OG^S+/#]*66D
MR/'MS0W_%DSNG=YB_3,%:J%&NL&320):FEB,',T9:!?\".<<)P)= V!!C-AF
M4.=.G4!WV2H*(9NQXPM;+L:6.\O"EI<A@_G8Q!([)#<8=:!5EJ0AX\.$3=;K
M-/QT%Z8!&QN%OJ7!X ,3G#;SO=*'F,7[W];#^YWK9&3[VMSQT0(!,G7@0SXY
MST2>PF-Z!Q)A%2PY_36A>+ /X17'_M*8RE9:( B9R6M*:OMJ' ME6N]<8%J<
M@(T^>,C@DDKG6$.G: :<,PQZWB:'72M>CCI160M\5?!)*,UIYI,%1_@E$K,N
M.[$TA=#+I:)#:MGFO>MP".?#753%;94,B#M8$_+,19@9?,YS>U("/&TR8WD)
MPWB7'ANV6UH,,4K3=Y?(A/@G9._!N_*Q+O?!%A 3")LZSTB+[/H4&<Q%JUPF
M+*WG;<-!-W$LXV%]K3Z#-1V*4)I#(;C?H4Y4!M#,OMOC"[=$W4AEE*T@>HP_
M6]I@W;>NO@H,O+0'3^RTT#6HBS4R,:00YL]*:N=;W)?:WWP[#[N:HIF@2AA6
M8(XOJ@&PC-KD&F+P%]W\>-W\=EET<X_?MEO'B-'8J,WF6/^O9M9%ZX&4%QM?
M#C>MXF9K6BPCM5N^K@5":U,C:F,*Z;5&X,*QNCV6Y:J68DV/ +77=:B-\)%(
M$5OH,%*9'8KIJ5X(XS_8Y(9@@J *0Q!,Z>%ES!F!;'%?W>,$*)VK).U9+%=R
MZ>"3OT2#1/37\>?A8" SU(*K. E/A,VXPQ0TV!D"82Q&S\>H<PR^\?.V9Z_
MNE5CXU4!K;$5WHD5TJG9115][FAX[=F%8VJ-#J(&A(]/^WPXMWOTV>8;]GW
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M2']ZX?W))_O7DO"/*OT_4$L#!!0    ( !J'J5J(;<\\H1(  $!@   4
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MT3]0]^UJ+9OX%P#LGP3 OQSP/U!+ P04    "  :AZE:5SL+94X6  #@=@
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MS]U'/^_=ZH]%,5O\"Y: *&B_MSRN@>M!MD=!8;MUNL S;(ECC6N(&Q]%H5V
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M&G?Z/9@LE=.GP#3QA7H%%B)^ED:$B(G@[7.W=<S.B,?T])-ORP ?W;4!GF7
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M%P6&'LB,P#/@"TRL?Q^J(08E'8[:\U%C%6-X8" (G@?DEB?V!*8"9&A8/:"
M:H92XTIU'%+U.&1/7#L@XB,O]I"W#8'\5S5$7+-QT\/Q6">(L.ODA5DAN.@9
MAE!D?$*-/48Y0SRCX\5NV.0GH>6!=^E@AK<T!H8Y(T!K=,%Q2</@4M\3XV]T
M:300O+#LI&J-E:(-E3N/_0PAGGU;=OO37=LMZIQ*C3T.\5K1^?FY.*<X;VVS
MATB6@D=!S30E1YRZ+9X(7WG&,,_0D\<H7W#*F7(M+$!X ,&=\6KK%7[<D,F]
M;*/40L99'C"<9QE=:5"X%VTU'+G9V7A@-S(Z$&[OCDWT#",69#(Z=5%,#RF-
MG7M!K;>/'1*<V!.GXC"RMQ;A@'"/GMESS$65A-?H GNJ$FM0)!X%B@#5F@.Z
MP+/.%$_E(GW7#57Z&6.#EM@9QU5@MDW]BCL'6U/SY<?U+*OCQ#[H28+D+L;B
MAL9*.SP'6 /MITO4,,9C;\2%62-F,J^7C_-5*];PVT*#?]XU&AS&G - !G?N
M(=O#P+U?C"]W> WFZ[,L$OK>UT6F7Z"%I)0=H_CEL;W-C(/2P^[+78)KQ8.L
M(=CKXO;<="WL8QIO%P)_MW3,H(E9F/"H08OQ!/C1P![1PH DHB;\'!!"6"3#
M#J#S695,9-GP$2TZMV*M3!&LFT)G<BV:IV. B](%/3F.T![5BDMOED\"@]J$
MIOSZCEN]D(OJ6W+0?\OQ^)5' UM.*GYD^6+81]X>Z'=+O]ORX*-IIB-./+V4
M5V38/('\_^$2AN6-U)J62H%>82F6N_R![K+P^GU1VHS L4KPPB<EUER.':P9
M\8+_D )EX4G/Z:[[B(3#]_!B#)O5!#!8_ZXV=USA^PP&1OO""47W.C<$1])&
M_"PQ:PS,\'$#^AL/%)#$&XDH=1\&.?& ;@6^M3%X=Q4!&MVRXCQ%&P/TC_!)
M>_O,5W?[SM^\\K-Y.&3[YT._11QEL7+*H^J[X#HOM.C85\F_60S2!9&7%>ZB
M#7:7WFG 8/4'O%J'N<2"U"(0.@ Z,\V*<H/^,$B,>=B"*G0P+$05V.%]84,L
M"MT4K]5D4SP$%ZG<$SN;V/1& OO VN/OP';7Q1@G/K[?[_G,!JK:H;^IN-97
M%S/ ^)R-PG$BRMWZ"Z"6R-+ETWT5*)#/((_ U6KLCK^O,!;=NAJYZRK%CB8:
M 3];K1;>W-1*"C@A?6%05VK#\G+/]DK.#WFFZ:I"X-<LW4AT"CL[O+,%%GA)
M>S<&ZB]Q"M:%H9MA*3<U K]^NGA16RL48RGM0AX'4W,;Q$7M[3Y,*V4\TRG>
MEH5G ^Z_(;$K?'KP#'BZO3>;R^.NN5>R<:&V"T#SV[=P>[:KD%FX.1OO)"OT
M"!<-#_2U;\NNK[K>Q&SNO;_]]0;E&X^_O?*-Q]_+-S[#A<FT=!]SF7;[#''P
MIQ3NJTG];>\/O\G-W7<A"_V9#4+AQDU3R%$;AR7^#DC\)+C#XJ4$@O2-P/&3
MF\/QE\/&+?P+M0?T)VOQ+]O^#U!+ P04    "  :AZE:T$)[G;H<   ;Y
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M2S[+L0S%!2-GL^M&NSS^@NTTQC[/> :'0/.W .=Y[']$E^DI'@W> 24=B[6
M=5TY)27324F5;J1X5(IUG.XZR8I?@!T1D@:+S[H(\FQ(-:CB:&!/ZD,;5A*;
M-)C2,2 *:@_=S]Q7#26V($L6FZ;(VO@G;X!_\DOS;^U(K?HMYZF/(#\SCQ,;
MX''BI7F\=J36^3GME^5W<@/\3KXTO]>.U.,^9_Y,'%TCRY*+'+"U<6MM )=,
MF(#?8^:MB."[4?Z]=U*F#B5'N(#NX"5(JLK$=X UL0]9-3!B(]\/:Z=$-94^
M,FPWT!GS@K-UQ2A3FV2;"(.FIEA^]5MB>_7;FJ]^>SYFS\:\]>KQ>;%Q5:O4
M-Q?K/N,V\F7?LOMX:YIC<M5UZPIX<B4TNNQ.Z5N:H\'\E8'2H08PLJ@XN/$N
MY1+)B-L1;U'C%[#Q$@K\I+A"^S;?@-:PXJ)G6GR:)B,V ":^9J\Y-CSH4+WE
MW0#'#;O;H,,LUC<<,\2'HWVG8UI@HM176JRP2J9O^0XUYBB>FHB8#99GU@G_
M6P^-@/4J8$--4*N)-3'+2;9LZD:QU*B>5DC]1[U1.:N31J7T^?SB].+XAQ>9
MG9=B<P+[.8/NDU=$IM4I-#OK!DDP_KQQ<([JX<0"GP%^/J-# 7\NXMYZZ:(Q
MWS5Z=#(O 9 >#O-/2E<]?H<S [.1 ZVP9^^1BD[1\3F+D4/-N@4K.L3/:VBO
M65 ?+9QKV%):!FX0&9]5ZM=%3\VA>)_H6LCZB+$6 U_J:*Q%QKLI[N'2A?[Y
M:UQKEWO>R7URP9/!=IZ<4MMY+8[X\]R([)NES@!L/%2<)P-UL$^J9?[#33Q[
M> -.(3-L)!('@W=C7P9'O]3*2?NV^+76W"NV!K_DZZO?"6;_^CPHG0Q+5<-4
ME=N!;M0^_[1:]<9'\TY.U<SC0^V893_FOIHU[:OLJ-7LN?Z-U>[O?U-'OSHS
M[<J78R7^_:Y^RC*'E_=.]H0Z/^3O2O8R4]3+P[*AZV>]HQH[/AE<-IM'9]4O
MO<ODQV]7?[0C^L6H'@\R\>J=T3OI.57]^+?ZK:S\OE*.:[^OZ7DC4<U^^9*[
MKIGT1^NWG:E^ZYU_J7Y)5<R]^^-CY:I>OJM=G7X\R70:@\M:K7A12;;/X^E+
MR?H]^$-/D[<_RU?RG9V^R'W^6"[?VR?UWM=/@B)[35,=XK\=IZL7_@=02P$"
M% ,4    "  :AZE:R8@D0C #  #T"P  $0              @ $     =&-M
M9"TR,#(U,#4P-RYX<V102P$"% ,4    "  :AZE:)"[-C/P*  !_A@  %0
M            @ %? P  =&-M9"TR,#(U,#4P-U]L86(N>&UL4$L! A0#%
M  @ &H>I6EB5ES9<!P  X%<  !4              ( !C@X  '1C;60M,C R
M-3 U,#=?<')E+GAM;%!+ 0(4 Q0    ( !J'J5J=F0,VRD\  ._T 0 4
M          "  1T6  !T;3(U,30V-#%D,5\Q,"TQ+FAT;5!+ 0(4 Q0    (
M !J'J5I!LV$Q.Q,  %MI   4              "  1EF  !T;3(U,30V-#%D
M,5\Q,"TR+FAT;5!+ 0(4 Q0    ( !J'J5J(;<\\H1(  $!@   4
M      "  89Y  !T;3(U,30V-#%D,5\Q,"TS+FAT;5!+ 0(4 Q0    ( !J'
MJ5I7.PME3A8  .!V   4              "  5F,  !T;3(U,30V-#%D,5\Q
M,"TT+FAT;5!+ 0(4 Q0    ( !J'J5K00GN=NAP  !OD   2
M  "  =FB  !T;3(U,30V-#%D,5\X:RYH=&U02P4&      @ "  - @  P[\
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>tm2514641d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tcmd-20250507.xsd" xlink:type="simple"/>
    <context id="AsOf2025-05-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001027838</identifier>
        </entity>
        <period>
            <startDate>2025-05-07</startDate>
            <endDate>2025-05-07</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-05-07" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-05-07" id="Fact000004">0001027838</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="AsOf2025-05-07" id="xdx2ixbrl0012">TACTILE SYSTEMS TECHNOLOGY INC</dei:EntityRegistrantName>
    <dei:DocumentType contextRef="AsOf2025-05-07" id="Fact000010">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-05-07" id="Fact000011">2025-05-07</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-05-07" id="Fact000013">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-05-07" id="Fact000014">001-37799</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-05-07" id="Fact000015">41-1801204</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-05-07" id="Fact000016">3701 Wayzata Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-05-07" id="Fact000017">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-05-07" id="Fact000018">Minneapolis</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-05-07" id="Fact000019">MN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-05-07" id="Fact000020">55416</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-05-07" id="Fact000021">612</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-05-07" id="Fact000022">355-5100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-05-07" id="Fact000023">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-05-07" id="Fact000024">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-05-07" id="Fact000025">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-05-07" id="Fact000026">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-05-07" id="Fact000027">Common     Stock, Par Value $0.001 Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-05-07" id="Fact000028">TCMD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-05-07" id="Fact000029">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-05-07" id="Fact000030">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
